as Borrower,
AND CERTAIN SUBSIDIARIES AND AFFILIATES OF AURORA DIAGNOSTICS, LLC,
as Guarantors,
as Administrative Agent and Collateral Agent,
AND UBS SECURITIES LLC,
as Joint Lead Arrangers and Joint Bookrunners,
as Syndication Agent
as Documentation Agent
Page | ||||
SECTION 1. DEFINITIONS AND INTERPRETATION | 2 | |||
1.1 Definitions | 2 | |||
1.2 Accounting Terms | 43 | |||
1.3 Interpretation, etc | 43 | |||
SECTION 2. LOANS | 44 | |||
2.1 Term Loans | 44 | |||
2.2 Revolving Loans | 44 | |||
2.3 Swing Line Loans. | 46 | |||
2.4 Issuance of Letters of Credit and Purchase of Participations Therein. | 48 | |||
2.5 Pro Rata Shares; Availability of Funds. | 52 | |||
2.6 Intentionally Omitted | 53 | |||
2.7 Evidence of Debt; Register; Lenders’ Books and Records; Notes | 53 | |||
2.8 Interest on Loans | 54 | |||
2.9 Conversion/Continuation | 56 | |||
2.10 Default Interest | 56 | |||
2.11 Fees | 57 | |||
2.12 Scheduled Payments | 58 | |||
2.13 Voluntary Prepayments/Commitment Reductions | 59 | |||
2.14 Mandatory Prepayments/Commitment Reductions | 61 | |||
2.15 Application of Prepayments/Reductions | 64 | |||
2.16 General Provisions Regarding Payments | 64 | |||
2.17 Ratable Sharing | 66 | |||
2.18 Making or Maintaining LIBOR Rate Loans | 67 | |||
2.19 Increased Costs; Capital Adequacy | 68 | |||
2.20 Taxes; Withholding, Etc. | 70 | |||
2.21 Obligation to Mitigate | 72 | |||
2.22 Defaulting Lenders | 73 | |||
2.23 Removal or Replacement of a Lender | 74 | |||
2.24 New Facilities | 75 | |||
SECTION 3. CONDITIONS PRECEDENT | 77 | |||
3.1 Closing Date | 77 | |||
3.2 Conditions to Each Credit Extension | 81 | |||
SECTION 4. REPRESENTATIONS AND WARRANTIES | 82 | |||
4.1 Organization; Requisite Power and Authority; Qualification | 82 | |||
4.2 Capital Stock and Ownership | 82 | |||
4.3 Due Authorization | 82 | |||
4.4 No Conflict | 82 | |||
4.5 Governmental Consents | 83 | |||
4.6 Binding Obligation | 83 | |||
4.7 Historical Financial Statements | 83 |
- i -
Page | ||||
4.8 Projections | 84 | |||
4.9 No Material Adverse Change | 84 | |||
4.10 Intentionally Omitted. | 84 | |||
4.11 Adverse Proceedings, etc | 84 | |||
4.12 Payment of Taxes | 84 | |||
4.13 Properties | 85 | |||
4.14 Environmental Matters | 85 | |||
4.15 No Defaults | 86 | |||
4.16 Material Contracts and Affiliated Practice Agreements | 86 | |||
4.17 Governmental Regulation | 86 | |||
4.18 Margin Stock | 86 | |||
4.19 Employee Matters | 86 | |||
4.20 Employee Benefit Plans | 87 | |||
4.21 Certain Fees | 88 | |||
4.22 Solvency | 88 | |||
4.23 Compliance with Statutes, etc | 88 | |||
4.24 Disclosure | 89 | |||
4.25 Patriot Act | 89 | |||
4.26 Insurance | 89 | |||
4.27 Security Interest in Collateral | 90 | |||
4.28 Permits, Etc | 90 | |||
4.29 Reimbursement from Third Party Payors | 91 | |||
4.30 Common Enterprise | 91 | |||
4.31 Intellectual Property | 91 | |||
4.32 Sanctioned Persons and Anti-Money Laundering | 92 | |||
SECTION 5. AFFIRMATIVE COVENANTS | 92 | |||
5.1 Financial Statements and Other Reports | 92 | |||
5.2 Existence | 96 | |||
5.3 Payment of Taxes and Claims | 97 | |||
5.4 Maintenance of Properties | 97 | |||
5.5 Insurance | 97 | |||
5.6 Books and Records; Inspections | 98 | |||
5.7 Lenders Meetings | 99 | |||
5.8 Compliance with Laws | 99 | |||
5.9 Environmental | 99 | |||
5.10 Subsidiaries; Guarantors | 100 | |||
5.11 Additional Material Real Estate Assets | 102 | |||
5.12 Interest Rate Protection | 103 | |||
5.13 Intentionally Omitted. | 103 | |||
5.14 Further Assurances | 104 | |||
5.15 Miscellaneous Business Covenants | 104 | |||
5.16 Use of Proceeds | 104 | |||
5.17 Compliance Program | 105 | |||
5.18 Maintenance of Ratings | 105 | |||
SECTION 6. NEGATIVE COVENANTS | 105 |
- ii -
Page | ||||
6.1 Indebtedness | 105 | |||
6.2 Liens | 108 | |||
6.3 Equitable Lien | 110 | |||
6.4 No Further Negative Pledges | 110 | |||
6.5 Restricted Junior Payments | 111 | |||
6.6 Restrictions on Subsidiary Distributions | 112 | |||
6.7 Investments | 113 | |||
6.8 Financial Covenants | 114 | |||
6.9 Fundamental Changes; Disposition of Assets; Acquisitions | 117 | |||
6.10 Disposal of Subsidiary Interests | 118 | |||
6.11 Sales and Lease Backs | 118 | |||
6.12 Transactions with Shareholders and Affiliates | 118 | |||
6.13 Conduct of Business | 119 | |||
6.14 Permitted Activities of Holdings | 119 | |||
6.15 Amendments or Waivers of with respect to Subordinated Indebtedness | 119 | |||
6.16 Fiscal Year | 120 | |||
6.17 Controlled Accounts | 120 | |||
6.18 Amendments to Organizational Agreements, Material Contracts and Affiliated Practice Agreements | 120 | |||
6.19 Prepayments of Subordinated Indebtedness | 121 | |||
6.20 Public Parent Prospectus; Reorganization Transactions | 121 | |||
6.21 Certain TRA Obligations | 121 | |||
SECTION 7. GUARANTY | 122 | |||
7.1 Guaranty of the Obligations | 122 | |||
7.2 Contribution by Guarantors | 122 | |||
7.3 Payment by Guarantors | 123 | |||
7.4 Liability of Guarantors Absolute | 123 | |||
7.5 Waivers by Guarantors | 125 | |||
7.6 Guarantors’ Rights of Subrogation, Contribution, etc | 126 | |||
7.7 Subordination of Other Obligations | 127 | |||
7.8 Continuing Guaranty | 127 | |||
7.9 Authority of Guarantors or Borrower | 127 | |||
7.10 Financial Condition Borrower | 127 | |||
7.11 Bankruptcy, etc | 128 | |||
7.12 Discharge of Guaranty Upon Sale of Guarantor | 128 | |||
7.13 Taxes | 129 | |||
SECTION 8. EVENTS OF DEFAULT | 129 | |||
8.1 Events of Default | 129 | |||
SECTION 9. AGENTS | 132 | |||
9.1 Appointment of Agents | 132 | |||
9.2 Powers and Duties | 133 | |||
9.3 General Immunity | 134 | |||
9.4 Agents Entitled to Act as Lender | 135 | |||
9.5 Lenders’ Representations, Warranties and Acknowledgment | 136 |
- iii -
Page | ||||
9.6 Right to Indemnity | 136 | |||
9.7 Successor Administrative Agent, Collateral Agent and Swing Line Lender | 137 | |||
9.8 Collateral Documents and Guaranty | 139 | |||
9.9 Withholding Taxes | 140 | |||
9.10 Administrative Agent May File Proofs of Claim | 140 | |||
SECTION 10. MISCELLANEOUS | 141 | |||
10.1 Notices Generally | 141 | |||
10.2 Expenses | 142 | |||
10.3 Indemnity | 143 | |||
10.4 Set Off | 144 | |||
10.5 Amendments and Waivers | 144 | |||
10.6 Successors and Assigns; Participations | 147 | |||
10.7 Independence of Covenants | 152 | |||
10.8 Survival of Representations, Warranties and Agreements | 152 | |||
10.9 No Waiver; Remedies Cumulative | 152 | |||
10.10 Marshalling; Payments Set Aside | 152 | |||
10.11 Severability | 153 | |||
10.12 Obligations Several; Independent Nature of Lenders’ Rights | 153 | |||
10.13 Headings | 153 | |||
10.14 APPLICABLE LAW | 153 | |||
10.15 CONSENT TO JURISDICTION | 153 | |||
10.16 WAIVER OF JURY TRIAL | 154 | |||
10.17 Confidentiality | 154 | |||
10.18 Usury Savings Clause | 155 | |||
10.19 Counterparts | 156 | |||
10.20 Effectiveness; Entire Agreement; No Third Party Beneficiaries | 156 | |||
10.21 Patriot Act | 156 | |||
10.22 Disclosure | 156 | |||
10.23 Appointment for Perfection | 157 | |||
10.24 Advertising and Publicity | 157 | |||
10.25 Borrower as representative for Credit Parties | 157 | |||
10.26 No Fiduciary Duty | 158 | |||
10.27 Affiliate Lenders | 158 |
- iv -
APPENDICES: | A-1 | Tranche B Term Loan Commitments | ||
A-2 | Revolving Commitments | |||
B | Notice Addresses | |||
SCHEDULES: | A | Consolidated Adjusted EBITDA Addbacks | ||
B | Baseline Earnout Amounts | |||
S | Seller Notes | |||
3.1 | Local Counsel | |||
4.1 | Jurisdictions of Organization and Qualification | |||
4.2 | Capital Stock and Ownership | |||
4.4 | No Conflict | |||
4.5 | Governmental Consents | |||
4.11 | Adverse Proceedings | |||
4.13 | Real Estate Assets | |||
4.16 | Material Contracts | |||
4.21 | Certain Fees | |||
4.26 | Insurance | |||
4.31 | Intellectual Property | |||
6.1(i) | Certain Indebtedness | |||
6.1(o) | Specified Earnouts | |||
6.2 | Certain Liens | |||
6.6 | Restrictions on Subsidiary Distributions | |||
6.7 | Certain Investments | |||
6.9 | Dispositions | |||
6.12 | Certain Affiliate Transactions | |||
EXHIBITS: | A-1 | Funding Notice | ||
A-2 | Conversion/Continuation Notice | |||
B-1 | Tranche B Term Loan Note | |||
B-2 | Revolving Loan Note | |||
B-3 | Swing Line Note | |||
C | Compliance Certificate | |||
D | Opinions of Counsel | |||
E | Assignment Agreement | |||
F-1 | Closing Date Certificate | |||
F-2 | Solvency Certificate | |||
G | Counterpart Agreement | |||
H | Form of Subordination Provisions | |||
I | Pledge and Security Agreement | |||
J | Landlord Personal Property Collateral Access Agreement | |||
K | Joinder Agreement | |||
L | Affiliated Practice Pledge Agreement | |||
M | Collateral Assignment of Nominee Agreement | |||
N | Collateral Assignment of Purchase Agreement | |||
O | Collateral Assignment of Services Agreement | |||
P | Collateral Assignment of Management Agreement |
- v -
Q | TRA Form | |||
R | Form of Affiliate Lender Assignment Agreement | |||
S | Holdings Amended Limited Liability Company Agreement | |||
T | Intercompany Subordination Agreement |
- vi -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
Tranche B Term Loan | ||||
Amortization Date | Installments | |||
September 30, 2010 | $ | 562,500 | ||
December 31, 2010 | $ | 562,500 |
58
Tranche B Term Loan | ||||
Amortization Date | Installments | |||
March 31, 2011 | $ | 562,500 | ||
June 30, 2011 | $ | 562,500 | ||
September 30, 2011 | $ | 562,500 | ||
December 31, 2011 | $ | 562,500 | ||
March 31, 2012 | $ | 562,500 | ||
June 30, 2012 | $ | 562,500 | ||
September 30, 2012 | $ | 562,500 | ||
December 31, 2012 | $ | 562,500 | ||
March 31, 2013 | $ | 562,500 | ||
June 30, 2013 | $ | 562,500 | ||
September 30, 2013 | $ | 562,500 | ||
December 31, 2013 | $ | 562,500 | ||
March 31, 2014 | $ | 562,500 | ||
June 30, 2014 | $ | 562,500 | ||
September 30, 2014 | $ | 562,500 | ||
December 31, 2014 | $ | 562,500 | ||
March 31, 2015 | $ | 562,500 | ||
June 30, 2015 | $ | 562,500 | ||
September 30, 2015 | $ | 562,500 | ||
December 31, 2015 | $ | 562,500 | ||
March 31, 2016 | $ | 562,500 | ||
May 26, 2016 | $ | 212,062,500 |
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
Fiscal | Interest Coverage | |
Quarter | Ratio | |
September 30, 2010 | 3.50:1.00 | |
December 31, 2010 | 3.50:1.00 | |
March 31, 2011 | 3.75:1.00 | |
June 30, 2011 | 3.75:1.00 | |
September 30, 2011 | 3.75:1.00 | |
December 31, 2011 | 3.75:1.00 | |
March 31, 2012 | 4.00:1.00 | |
June 30, 2012 | 4.00:1.00 | |
September 30, 2012 | 4.00:1.00 | |
December 31, 2012 | 4.00:1.00 | |
March 31, 2013 | 4.00:1.00 | |
June 30, 2013 | 4.25:1.00 | |
September 30, 2013 | 4.25:1.00 | |
December 31, 2013 | 4.25:1.00 | |
March 31, 2014 | 4.25:1.00 | |
June 30, 2014 | 4.25:1.00 | |
September 30, 2014 | 4.25:1.00 | |
December 31, 2014 and thereafter | 4.25:1.00 |
Fiscal | Leverage | |
Quarter | Ratio | |
September 30, 2010 | 5.25:1.00 | |
December 31, 2010 | 5.00:1.00 | |
March 31, 2011 | 4.75:1.00 | |
June 30, 2011 | 4.50:1.00 | |
September 30, 2011 | 4.50:1.00 | |
December 31, 2011 | 4.25:1.00 | |
March 31, 2012 | 4.00:1.00 | |
June 30, 2012 | 4.00:1.00 | |
September 30, 2012 | 3.75:1.00 | |
December 31, 2012 | 3.75:1.00 | |
March 31, 2013 | 3.50:1.00 | |
June 30, 2013 | 3.50:1.00 | |
September 30, 2013 | 3.25:1.00 | |
December 31, 2013 | 3.25:1.00 |
115
Fiscal | Leverage | |
Quarter | Ratio | |
March 31, 2014 | 3.00:1.00 | |
June 30, 2014 | 3.00:1.00 | |
September 30, 2014 | 3.00:1.00 | |
December 31, 2014 and thereafter | 3.00:1.00 |
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
BORROWER: AURORA DIAGNOSTICS, LLC | ||||
By: | /s/ Gregory A. Marsh | |||
Name: | Gregory A. Marsh | |||
Title: | Vice President, Chief Financial Officer & Treasurer | |||
HOLDINGS: AURORA DIAGNOSTICS HOLDINGS, LLC | ||||
By: | /s/ Gregory A. Marsh | |||
Name: | Gregory A. Marsh | |||
Title: | Vice President, Chief Financial Officer & Treasurer | |||
[SIGNATURE PAGE]
GUARANTORS: AURORA GREENSBORO, LLC AURORA LMC, LLC AURORA MASSACHUSETTS, LLC AURORA MICHIGAN, LLC AURORA NEW HAMPSHIRE, LLC BERNHARDT LABORATORIES, INC. C R COLLECTIONS, LLC COVENANT HEALTHCARE LAB, LLC CUNNINGHAM PATHOLOGY, L.L.C. GREENSBORO PATHOLOGY, LLC HARDMAN PATHOLOGY ADX, LLC LABORATORY OF DERMATOPATHOLOGY ADX, LLC MARK & KAMBOUR, LLC MARK & KAMBOUR HOLDINGS, INC. PATHOLOGY SOLUTIONS, LLC SEACOAST PATHOLOGY, INC. TWIN CITIES DERMATOPATHOLOGY, LLC | ||||
By: | /s/ Gregory A. Marsh | |||
Name: | Gregory A. Marsh | |||
Title: | Vice President, Chief Financial Officer & Treasurer |
[SIGNATURE PAGE]
BARCLAYS BANK PLC, as Administrative Agent, Collateral Agent, Swing Line Lender, Issuing Bank and Lender | ||||
By: | /s/ Diane Rolfe | |||
Name: Diane Rolfe | ||||
Title: Director | ||||
[SIGNATURE PAGE]
MORGAN STANLEY SENIOR FUNDING, INC., as Lender | ||||
By: | /s/ Peter Zippelius | |||
Name: Peter Zippelius | ||||
Title: Authorized Signatory | ||||
[SIGNATURE PAGE]
UBS LOAN FINANCE LLC, as Lender | ||||
By: | /s/ Irja R. Otsa | |||
Name: Irja R. Otsa | ||||
Title: Associate Director | ||||
By: | /s/ Mary E. Evans | |||
Name: Mary E. Evans | ||||
Title: Associate Director | ||||
[SIGNATURE PAGE]
ROYAL BANK OF CANADA, as Lender | ||||
By: | /s/ Mustafa S. Toplwalla | |||
Name: Mustafa S. Toplwalla | ||||
Title: Authorized Signatory | ||||
[SIGNATURE PAGE]
BANK OF MONTREAL, as Lender | ||||
By: | /s/ Bryan J. Rolfe | |||
Name: Bryan J. Rolfe | ||||
Title: Managing Director | ||||
[SIGNATURE PAGE] | Aurora — Credit Agreement |
Tranche B | Pro | |||||||
Lender | Term Loan Commitment | Rata Share | ||||||
BARCLAYS BANK PLC | $ | 225,000,000 | 100.0 | % | ||||
TOTAL | $ | 225,000,000 | 100.0 | % |
Appendix A-1
Pro Rata | ||||||||||||||||
Revolving Commitment | Share | |||||||||||||||
Lender | Column 1 | Column 2 | Total | (%) | ||||||||||||
BARCLAYS BANK PLC | $ | 10,454,545 | $ | 12,545,455 | $ | 23,000,000 | 20.91 | % | ||||||||
MORGAN STANLEY SENIOR FUNDING, INC. | $ | 15,909,091 | $ | 19,090,909 | $ | 35,000,000 | 31.82 | % | ||||||||
UBS LOAN FINANCE LLC | $ | 12,727,272 | $ | 15,272,728 | $ | 28,000,000 | 25.45 | % | ||||||||
ROYAL BANK OF CANADA | $ | 5,454,546 | $ | 6,545,454 | $ | 12,000,000 | 10.91 | % | ||||||||
BANK OF MONTREAL | $ | 5,454,546 | $ | 6,545,454 | $ | 12,000,000 | 10.91 | % | ||||||||
TOTAL | $ | 50,000,000 | $ | 60,000,000 | $ | 110,000,000 | 100.00 | % |
Appendix A-2
Palm Beach Gardens, Florida 33418
Attention: James C. New, Chief Executive Officer
Telephone: 561-626-5512
Telecopier: 561-626-4530
Boston, Massachusetts 02116
Attention: Peter Connolly
Telephone: 617-824-1100
Telecopier: 617-824-1187
1515 Arapahoe St.
Tower I, Suite 1500
Denver, CO 80202
Attention: Christopher J. Bock
Telephone: 303-390-5020
Telecopier: 303-390-5015
1201 West Peachtree Street
Atlanta, Georgia 30309
Attention: Deanna L. Kashdan
Telephone: 404-881-7782
Telecopier: 404-253-8299
Appendix B
as Administrative Agent, Collateral Agent, Swing Line Lender, Issuing Bank and a Lender
New York, NY 10019
Attention: Diane Rolfe
Telephone: 212-526-1109
Telecopier: 212-526-5115
Email: diane.rolfe@barcap.com
as a Lender
Baltimore, MD 21202
Attention: Morgan Stanley Loan Servicing
Telephone: 443-627-4355
Telecopier: 718-233-2140
Email: msloanservicing@morganstanley.com
as a Lender
677 Washington Blvd.
Stamford, CT 06901
Attention: Jenny E. Milioti
Telephone: 203-719-5993
Telecopier: 203-719-3888
Email: jenny.milioti@ubs.com
as a Lender
One Liberty Plaza
4th Floor
New York, NY 10006-1404
Attention: Manager
Telephone: 877-332-7455
Telecopier: 212-428-2372
Appendix B
as a Lender
Chicago, IL 60603
Attention: Shequitis Booker
Telephone: 312-461-7602
Email: shequitis.booker@harrisbank.com
Appendix B
Total | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | |||||||||||||||||||||||||
Cunningham | $ | 9,000 | $ | — | $ | 3,000 | $ | 3,000 | $ | 3,000 | $ | — | $ | — | $ | — | ||||||||||||||||
Kent | 1,387 | — | 1,387 | — | — | — | — | |||||||||||||||||||||||||
Greensboro Pathology | 13,200 | — | — | 4,400 | 4,400 | 4,400 | — | — | ||||||||||||||||||||||||
Mark & Kambour Pathology Associates | 2,000 | — | — | 2,000 | — | — | — | — | ||||||||||||||||||||||||
Laboratory Medicine Consultants | 7,380 | — | — | 2,460 | 2,460 | 2,460 | — | — | ||||||||||||||||||||||||
CHC Labs | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||
Subtotal Contingent Notes (includes Guaranteed Notes) | 32,967 | — | 4,387 | 11,860 | 9,860 | 6,860 | — | — | ||||||||||||||||||||||||
Twin Cities | 4,848 | — | 2,424 | 2,424 | — | — | — | — | ||||||||||||||||||||||||
South Texas | 2,600 | — | 867 | 867 | 867 | — | — | — | ||||||||||||||||||||||||
Bernhardt | 2,676 | — | — | 892 | 892 | 892 | — | — | ||||||||||||||||||||||||
Path Solutions | 11,500 | — | — | 3,833 | 3,833 | 3,833 | — | — | ||||||||||||||||||||||||
Pinkus | 3,000 | — | — | 600 | 600 | 600 | 600 | 600 | ||||||||||||||||||||||||
Total | $ | 57,591 | $ | — | $ | 7,678 | $ | 20,476 | $ | 16,052 | $ | 12,185 | $ | 600 | $ | 600 | ||||||||||||||||
States where Qualified to | ||||
Company Name | State of Organization | do Business | ||
Aurora Diagnostics, LLC | Delaware | Florida | ||
Aurora Diagnostics Holdings, LLC | Delaware | N/A | ||
Hardman Pathology ADX, LLC | Georgia | N/A | ||
Aurora Michigan, LLC | Michigan | N/A | ||
Aurora New Hampshire, LLC | New Hampshire | N/A | ||
Laboratory of Dermatopathology ADX, LLC | New York | N/A | ||
Cunningham Pathology, L.L.C. | Delaware | Alabama | ||
C R Collections, LLC | Alabama | N/A | ||
Seacoast Pathology, Inc. | New Hampshire | N/A | ||
Mark & Kambour, LLC | Florida | N/A | ||
Aurora Greensboro, LLC | North Carolina | N/A | ||
Greensboro Pathology, LLC | North Carolina | N/A | ||
Aurora LMC, LLC | Nevada | N/A | ||
Covenant Healthcare Lab, LLC | Florida | N/A | ||
Twin Cities Dermatopathology, LLC | Minnesota | N/A | ||
Aurora Massachusetts, LLC | Delaware | Massachusetts |
States where Qualified to | ||||
Company Name | State of Organization | do Business | ||
Connecticut | ||||
Florida | ||||
Georgia | ||||
Maryland | ||||
New York | ||||
Pathology Solutions, LLC | New Jersey | North Carolina | ||
Ohio | ||||
Pennsylvania | ||||
South Carolina | ||||
Virginia | ||||
Bernhardt Laboratories, Inc. | Florida | N/A | ||
Mark & Kambour Holdings, Inc. | Florida | N/A |
- 6 -
Certificate | No. Shares/ | Percent | ||||||
Record Owner - Grantor | Current Legal Entity | No. | Interest | Pledged | ||||
Aurora Diagnostics Holdings, LLC | Aurora Diagnostics, LLC | C-1 | 1000 Units / 100% | 100% | ||||
Aurora Diagnostics, LLC | Hardman Pathology ADX, LLC | C-2 | 1000 Units / 100% | 100% | ||||
Aurora Diagnostics, LLC | Aurora Michigan, LLC | C-1 | 1000 Units / 100% | 100% | ||||
Aurora Diagnostics, LLC | Aurora New Hampshire, LLC | C-1 | 1000 Units / 100% | 100% | ||||
Aurora Diagnostics, LLC | Laboratory of Dermatopathology ADX, LLC | C-2 | 1000 Units / 100% | 100% | ||||
Aurora Diagnostics, LLC | Cunningham Pathology, L.L.C. | N/A | 100% | 100% | ||||
Aurora Diagnostics, LLC | Aurora Greensboro, LLC | N/A | N/A | 100% | ||||
Aurora Diagnostics, LLC | Mark & Kambour, LLC | N/A | N/A | 100% | ||||
Cunningham Pathology, L.L.C. | C R Collections, LLC | N/A | 100% | 100% | ||||
Aurora New Hampshire, LLC | Seacoast Pathology, Inc. | 4 | 300 Shares / 100% | 100% | ||||
Aurora Greensboro, LLC | Greensboro Pathology, LLC | N/A | N/A | 100% | ||||
Aurora Diagnostics, LLC | Aurora LMC, LLC | N/A | N/A | 100% | ||||
Aurora Diagnostics, LLC | Covenant Healthcare Lab, LLC | N/A | N/A | 100% | ||||
Aurora Diagnostics, LLC | Twin Cities Dermatopathology, LLC | N/A | N/A | 100% |
Certificate | No. Shares/ | Percent | ||||||
Record Owner - Grantor | Current Legal Entity | No. | Interest | Pledged | ||||
Aurora Diagnostics, LLC | Skin Pathology ADX, LLC1 | N/A | N/A | 100% | ||||
Aurora Diagnostics, LLC | Aurora Massachusetts, LLC | N/A | N/A | 100% | ||||
Aurora Diagnostics, LLC | Pathology Solutions, LLC | N/A | N/A | 100% | ||||
Mark & Kambour, LLC | Mark & Kambour Holdings, Inc. | 1 | 100 Shares/100% | 100% | ||||
Mark & Kambour Holdings, Inc. | Bernhardt Laboratories, Inc. | 4 | 500 Shares/100% | 100% |
1 | Skin Pathology ADX, LLC was formed as an acquisition vehicle for Aurora Diagnostics, LLC in March 2008, but has not been capitalized. |
- 8 -
Leasehold | Name of Lease, Sublease or | Lease | Annual Base | |||||||
Company | Location | or Fee | Assignment2 | Expiration | Rent | |||||
Aurora Diagnostics, LLC | 11025 RCA Center Drive, Ste. 300, Palm Beach Gardens, FL 33410 | Leasehold | Lease Agreement, dated September 4, 2007, by and between PGA Development Associates, LLC and Aurora Diagnostics, LLC | 2/28/13 | $195,546.00 + 4% increase per year | |||||
Mark & Kambour, LLC, as successor to Aurora Florida, LLC | Freepath 4412 West Osborne Ave Tampa, FL 33614 | Leasehold | Commercial Lease Agreement, dated September 1, 2006, by and between Pathway Investments, L.L.C. and Mark & Kambour, LLC (as successor to Aurora Florida, LLC) | 8/31/11 | $60,000 per year | |||||
Hardman Pathology ADX, LLC (formerly known as Aurora Georgia, LLC) | Hardman Pathology 110 Trinity Place Athens, GA 30607 | Leasehold | Lease Agreement, dated March 21, 2007, by and between M, B, & H, L.L.C. and Hardman Pathology ADX, LLC (f/k/a Aurora Georgia, LLC) | 3/21/12 | $28,000 + 3% increase | |||||
Seacoast Pathology, Inc. | 1 Hampton Rd, Ste. 208 & 302 Exeter, NH 03833 | Leasehold | Commercial Lease Agreement, dated March 2004, by and between Brooks Properties II, LLC and Seacoast Pathology, Inc. (as successor in interest to Seacoast Pathology P.A.) | 4/30/13 | Suite 208: $54,800 + fixed increase Suite 302: $47,068 Four year extension is 85,200 per year |
2 | Include all amendments, modifications, supplements, renewals or extensions of any lease, sublease or assignment listed. |
Leasehold | Name of Lease, Sublease or | Lease | Annual Base | |||||||
Company | Location | or Fee | Assignment2 | Expiration | Rent | |||||
Laboratory of Dermatopathology ADX, LLC (formerly known as Aurora New York, LLC) | 2 North Plandome Rd Port Washington, NY 11050 | Leasehold | Agreement of Lease, dated October 1, 2006, by and between The Brownstein Family Limited Partnership and Laboratory of Dermatopathology ADX, LLC (f/k/a Aurora New York, LLC) | 9/30/11 | $180,000 + 2.25% increase per year | |||||
Cunningham Pathology, L.L.C. | 924 Montclair Rd, Ste. 200 Birmingham, AL 35213 | Leasehold | Indenture of Lease, dated April 30, 2007, by and between Cunningham Investment Group LLC and Cunningham Pathology, LLC | 4/30/17 | $284,862 + fixed increase | |||||
Mark & Kambour, LLC | 4665 Ponce de Leon Blvd Coral Gables, FL 33146 | Leasehold | Lease, dated 2007, by and between Coury Investments, Limited and Mark & Kambour, LLC (as assignee of Mark & Kambour, M.D., P.A.) | 09/20/12 | $115,702 + 4% increase per year | |||||
Greensboro Pathology, LLC | 706 Green Valley Rd, Ste 104 & 105 Greensboro, NC 27408 | Leasehold | Lease Agreement, dated August 13, 2001, by and between Friendly Associates Limited Partnership XXII, Starmount Company and Greensboro Pathology LLC, (as successor in interest to Greensboro Pathology Associates, PA), as amended by that certain Amendment of Lease Agreement dated January 30, 2002 and that certain Second Amendment of Lease Agreement dated April 16, 2009, as assigned to SEBR 706, LLC. | 12/31/19 | Rental amount $0 during 4/1/2009-12/31/2012; beginning 1/1/2013 annual rent of $87,786 + 1.5% annual increase |
- 13 -
Leasehold | Name of Lease, Sublease or | Lease | Annual Base | |||||||
Company | Location | or Fee | Assignment2 | Expiration | Rent | |||||
Covenant Healthcare Lab, LLC | 3824 E US HWY 90 Lake City, FL 32055 | Leasehold | Lease, dated April 15, 2002, by and between Covenant Healthcare Lab, LLC (formerly CHC Labs, Inc.) and City of Lake City, Florida | 8/31/11 | $535 per month | |||||
Covenant Healthcare Lab, LLC | 4134 W HWY 90, Ste 115 Lake City, FL 32024 | Leasehold | Commercial Lease Agreement, dated September 1, 2005, by and between Covenant Healthcare Lab, LLC (formerly CHC Labs, Inc.) and Accurate Realty Investments, LLLP | Month-to-month | $600 per month | |||||
Covenant Healthcare Lab, LLC | 2126 North Young Blvd Chiefland, FL 32626 | Leasehold | Commercial Lease Agreement, dated May 12, 2006, by and between Covenant Healthcare Lab, LLC (formerly CHC Labs, Inc.) and Frank Drummond | Month-to-month | $600 per month | |||||
Covenant Healthcare Lab, LLC | 5106 Ohio Ave Live Oak, FL 32060 | Leasehold | Lease for premises located at 5106 Ohio Ave., Live Oak, Florida 32060, with Covenant Healthcare Lab, LLC, as tenant and Healthcore / Ken Watson as landlord | Month-to-month | $250 per month | |||||
Covenant Healthcare Lab, LLC | 404 N.W. Hall of Fame Dr Lake City, FL 32055 | Leasehold | Lease Agreement, dated October 2, 2007, by and among Covenant Healthcare Lab, LLC (formerly CHC Labs, Inc.), Lake City MOB Assoc. LLC and PRS-Springwood, LLC | 9/30/2010 | $2,490 per year |
- 14 -
Leasehold | Name of Lease, Sublease or | Lease | Annual Base | |||||||
Company | Location | or Fee | Assignment2 | Expiration | Rent | |||||
Covenant Healthcare Lab, LLC | Clyde Morris Medical & Professional Center 305 Clyde Morris Boulevard, Units 20, 21 and 22, Bldg A Ormond Beach, FL 32174 | Fee | N/A | N/A | N/A | |||||
Covenant Healthcare Lab, LLC | 15260 NW 147th Dr., Ste. 300, Alachua, FL 32615 | Leasehold | Lease, dated January 16, 2008, by and between Covenant Healthcare Lab, LLC (formerly CHC Labs, Inc.), and Dr. James McCauley | Month-to-month | $750 per month | |||||
Twin Cities Dermatopathology, LLC | 9909 South Shore Dr., Ste. 1A, Plymouth, NH 55441 | Leasehold | Lease, dated April 12, 1990, by and between Medicine Lake Properties of Plymouth and Twin Cities Dermatopathology, LLC (as successor in interest to Twin Lakes Dermatopathology, P.A.), together with that certain Addendum, dated April 12, 1990, together with that certain Lease Amendment dated February 2, 1992, that certain Lease Amendment dated July 26, 1994, that certain Lease Amendment dated February 28, 1996, that certain Lease Amendment dated January 29, 1999, that certain Lease Amendment dated August 22, 2002, that certain Lease Extension dated July 24, 1995, that certain Lease Extension dated June 30, 2005, and that certain Lease Extension dated April 2006 | 05/31/2011 | $51,687 + fixed per year increase |
- 15 -
Leasehold | Name of Lease, Sublease or | Lease | Annual Base | |||||||
Company | Location | or Fee | Assignment2 | Expiration | Rent | |||||
Pathology Solutions, LLC | 246 Industrial Way Eatontown, NJ 07724 | Leasehold | Lease Agreement, dated as of April 7, 2009, between Pathology Solutions, LLC and Industrial Way Complex, L.L.C. | 04/30/2012 | $119,592.00 annual rent | |||||
Bernhardt Laboratories, Inc. | 5008 Mustang Road Jacksonville, FL 32216 | Leasehold | Amended and Restated Lease Agreement, dated as of January 1, 2010, between Bernhardt Laboratories, Inc. and Regina T. Bernhardt. | 12/31/2014 | $8,800 per month plus sales tax | |||||
Covenant Healthcare Lab, LLC | 801 Pinewood Street Live Oak, FL 62064 | Leasehold | Oral lease for between Covenant Healthcare Lab, LLC as tenant and Dr. Janusek as landlord | Month-to-month | $300 per month | |||||
Covenant Healthcare Lab LLC | 11 South Blvd. Macclenny, FL 32063 | Leasehold | Commercial Lease Agreement, dated October 9, 2008, by and between St. Mary’s Realty Corporation and CHC LABS | 11/30/2010 | $1,050 per month | |||||
Aurora Massachusetts, LLC | 1 Center Plaza, Ste. 270 Boston, MA 02108 | Leasehold | Office Lease Agreement, dated January 21, 2010, between Aurora Massachusetts, LLC and Ma-Center Plaza, L.L.C. | 07/31/2015 | $63,043.56 months 1-16; $65,110.56 months 17-28; $67,177.56 months 29-40; $69,244.56; 41-52 months 53-64 |
- 16 -
Leasehold | Name of Lease, Sublease or | Lease | Annual Base | |||||||
Company | Location | or Fee | Assignment2 | Expiration | Rent | |||||
Cunningham Pathology, L.L.C. | 902 5th Ave. East Tuscaloosa, AL 35401 | Leasehold | Lease Agreement, dated May 1, 1999, by and between K & H Realty and Cunningham Pathology, LLC | Month-to-month | $10,040 per year | |||||
Cunningham Pathology, L.L.C. | 2010 Brookwood Medical Center Drive Birmingham, AL 35209 | Leasehold | Sublease Agreement, dated July 22, 2004, by and between Laboratory Corporation of America Holdings, Cunningham Pathology, L.L.C. and Brookwood Medical Center | Month-to-month | $1232.42 per month | |||||
Cunningham Pathology, L.L.C. | 2720 University Blvd. Birmingham, AL 35233 | Leasehold | Sublease Agreement, dated May 30, 2002, by and between Birmingham Outpatient Surgery Center, Ltd., and Cunningham Pathology, LLC, as amended by that certain First Amendment to Sublease Agreement, June 1, 2003, that certain Second Amendment to Sublease Agreement, dated May 1, 2004, and that certain Third Amendment to Sublease Agreement, dated March 8, 2007 | 04/30/2014 | $636.03 per month |
- 17 -
- 19 -
Insured | Insurer | Type of Policy | Policy # | |||||
All of the Credit Parties | Wausau Business Insurance Company | General Liability | TBJZ91453225019 | |||||
All of the Credit Parties | Wausau Business Insurance Company | Excess/Umbrella Liability | THCZ91453225039 | |||||
All of the Credit Parties | Wausau Underwriters Insurance Company | Workers Compensation | Z91453225029 | |||||
All of the Credit Parties | Great Northern Insurance Company | Commercial Auto | 73559872 |
Insured | Insurer | Type of Policy | Policy # | |||||
All of the Credit Parties | Great Northern Insurance Company | Property | 35881832 |
Insured | Insurer | Type of Policy | Policy # | |||
Aurora Diagnostics Holdings, LLC | XL Specialty Insurance Company | Management Liability Package | ELU11146009 |
Insured | Insurer | Type of Policy | Policy # | |||||
Aurora Diagnostics Holdings, LLC | Doctors Company Insurance Group | Medical Professional Liability | 0346428 |
Insured | Insurer | Type of Policy | Policy # | |||
Aurora Diagnostics Holdings, LLC, Laboratory of Dermatopathology ADX LLC | Landmark American Ins. Co. | Medical Professional Liability | LHM724257 |
App. Date/ | ||||||||||||
Mark | Country | Status | Reg. Date | App. No./ Reg. No. | Owner | |||||||
AURORA DIAGNOSTICS | US | Registered | 6/10/2008 | 3446899 | Aurora Diagnostics, LLC | |||||||
aurora diagnostics | ||||||||||||
CAREDX | US | Pending | 3/14/2010 | 77/958,561 | Aurora Diagnostics, LLC | |||||||
CONNECTDX THE INFORMATION GATEWAY | US | Registered | 4/7/2009 | 3,601,123 | Aurora Diagnostics, LLC | |||||||
DERMDX | US | Registered | 5/11/2010 | 3,787,236 | Aurora Diagnostics, LLC | |||||||
GASTRODX | US | Pending | 2/16/2010 | 77/936,186 | Aurora Diagnostics, LLC | |||||||
ORALDX | US | Pending | 3/14/2010 | 77/958,560 | Aurora Diagnostics, LLC | |||||||
TREATMENTDX | US | Pending | 11/6/2009 | 77/866,993 | Aurora Diagnostics, LLC | |||||||
URODX | US | Registered | 5/11/2010 | 3,787,237 | Aurora Diagnostics, LLC |
App. Date/ | ||||||||||||
Mark | Country | Status | Reg. Date | App. No./ Reg. No. | Owner | |||||||
WOMEN’SDX | US | Registered | 5/11/2010 | 3,787,239 | Aurora Diagnostics, LLC | |||||||
CUNNINGHAM PATHOLOGY ASSOCIATES P.A. | US | Registered | 9/29/1981 | 1171727 | Cunningham Pathology, LLC | |||||||
Design Only | US State Alabama | Registered | 7/8/2003 | 105-093 | Cunningham Pathology, LLC | |||||||
Company | Copyright Title | Registration Number | Registration Date | Registration Type | ||||
PATHOLOGY SOLUTIONS, LLC | Tiger TCPC | TX0006919076 | December 3, 2007 | Computer File |
Entity | Date Acquired | Maturity Date | ||
Cunningham Pathology, L.L.C. | 04/30/07 | 04/28/12 | ||
Greensboro Pathology, LLC | 10/03/07 | 10/04/12 | ||
Twin Cities Dermatopathology, LLC | 03/07/08 | 03/07/11 | ||
Kent Pathology Laboratory, PLLC | 05/31/07 | 05/31/10 | ||
Laboratory Medicine Consultants, Ltd. | 12/10/07 | 12/09/12 | ||
Mark & Kambour Pathology Associates | 10/11/07 | 10/10/10 |
Secured | ||||||||
UCC Type | Party/ | |||||||
Debtor | Jurisdiction | File # and File Date | Plaintiff | Collateral Description | ||||
Covenant Healthcare Lab, LLC | Florida, State | UCC-1 #200202081611 9/4/02 | Bankers/Softech Divisions of EAB Leasing Corp. | Equipment Lease; continued 4/13/07 (precautionary filing) | ||||
Covenant Healthcare Lab, LLC | Florida, State | UCC-1 #200000111522—7 5/12/00 | Bankers/Softech/Mid-States, a division of EAB Leasing | Equipment Lease; continued 11/16/04; lapse date 5/12/10 (precautionary filing) | ||||
Bernhardt Laboratories, Inc. | Florida, State | UCC-1 #200706884920 10/29/07 | Becton, Dickenson and Company | Equipment Lease (precautionary filing) | ||||
Bernhardt Laboratories, Inc. | Florida, State | UCC-1 #200900246969 3/26/09 | Caterpillar Financial Services Corporation | Equipment Lease (precautionary filing) | ||||
Seacoast Pathology, Inc. | New Hampshire, State | UCC-1 #20060009834C 4/26/06 | CM Financial Corporation | Equipment Lease (precautionary filing) | ||||
Greensboro Pathology, LLC | North Carolina, State | UCC-1 #20060037541K 4/13/06 | Cytyc Limited Partnership | Equipment (precautionary filing) | ||||
Bernhardt Laboratories, Inc. | Florida, State | UCC-1 #200408162196 10/26/04 | Cytyc Limited Partnership | Equipment Lease - lapse date 10/26/09 (precautionary filing) | ||||
Covenant Healthcare Lab, LLC | Florida, State | UCC-1 #200500119609 7/7/05 | Dade Behring, Inc. | Equipment Lease (precautionary filing) | ||||
Covenant Healthcare Lab, LLC | Florida, State | UCC-1 #200601818901 2/3/06 | Dade Behring, Inc. | Equipment Lease (precautionary filing) | ||||
Covenant Healthcare Lab, LLC | Florida, State | UCC-1 #200706131906 7/25/07 | Dade Behring, Inc. | Equipment Lease (precautionary filing) | ||||
Seacoast Pathology, Inc. | New Hampshire, State | UCC-1 #20060001857M 1/24/06 | DeLage Landen Financial Services, Inc. | Equipment Lease (precautionary filing) |
Secured | ||||||||
UCC Type | Party/ | |||||||
Debtor | Jurisdiction | File # and File Date | Plaintiff | Collateral Description | ||||
Covenant Healthcare Lab, LLC | Florida, State | UCC-1 #200900141989 3/9/09 | Dell Financial Services L.L.C. | Equipment Lease (precautionary filing) | ||||
Aurora Diagnostics, LLC | Delaware, State | UCC-1 #2007 3849378 10/12/07 | Heartland Business Credit | Capital Lease of a Benchmark XT Mobile | ||||
Bernhardt Laboratories, Inc. | Florida, State | UCC-1 #200900996526 8/7/09 | Hologic Limited Partnership | Equipment Lease (precautionary filing) | ||||
Greensboro Pathology, LLC | North Carolina, State | UCC-1 #20050055887A 6/13/05 | Marlin Leasing Corp | Equipment Lease (precautionary filing) | ||||
Greensboro Pathology, LLC | North Carolina, State | UCC-1 #20080088029J 9/30/08 | Marlin Leasing Corp | Equipment Lease (precautionary filing) | ||||
Greensboro Pathology, LLC | North Carolina, State | UCC-1 #20080097300M 10/31/08 | Marlin Leasing Corp | Equipment Lease (precautionary filing) | ||||
Greensboro Pathology, LLC | North Carolina, State | UCC-1 #20060031295K 3/29/06 | Republic Bank | Equipment Lease (precautionary filing) | ||||
Greensboro Pathology, LLC | North Carolina, State | UCC-1 #20090069359C 9/3/09 | Siemen’s Financial Services, Inc. | Equipment Lease; assigned by Siemen’s Diagnostics Finance Co. LLC 9/10/09 (precautionary filing) | ||||
Covenant Healthcare Lab, LLC | Florida, State | UCC-1 #200807934419 3/24/08 | Siemens Healthcare Diagnostics, Inc. | Equipment Lease (precautionary filing) | ||||
Seacoast Pathology, Inc. | New Hampshire, State | UCC-1 #20060027468G 11/15/06 | Tripath Imaging, Inc. | Equipment Lease (precautionary filing) | ||||
Aurora Diagnostics, LLC | Delaware, State | UCC-1 #2008 3016126 9/5/08 | US Bancorp | Equipment Lease (precautionary filing) | ||||
Seacoast Pathology, Inc. | New Hampshire, State | UCC-1 #20050027536A 11/22/05 | US Bank National Association | Equipment Lease; assigned by Leasing Associates of Barrington, Inc, 3/15/06 (precautionary filing) |
CREDIT AND GUARANTY AGREEMENT
o | Base Rate Loans: | $[___,___,___] | ||
o | LIBOR Rate Loans, with an Initial Interest Period of Month(s): | $[___,___,___] |
o | Base Rate Loans: | $[___,___,___] | ||
o | LIBOR Rate Loans, with an Initial Interest Period of Month(s): | $[___,___,___] |
o | Base Rate Loans: | $[___,___,___] | ||
o | LIBOR Rate Loans, with an Initial Interest Period of Month(s): | $[___,___,___] |
EXHIBIT A-1-1
AURORA DIAGNOSTICS, LLC | ||||
By: | ||||
Name: | ||||
Title: |
EXHIBIT A-1-2
CREDIT AND GUARANTY AGREEMENT
$[___,___,___] | LIBOR Rate Loans to be continued with Interest Period of ___ month(s) | |||
$[___,___,___] | Base Rate Loans to be converted to LIBOR Rate Loans with Interest Period of ___ month(s) | |||
$[___,___,___] | LIBOR Rate Loans to be converted to Base Rate Loans |
$[___,___,___] | LIBOR Rate Loans to be continued with Interest Period of ___ month(s) | |||
$[___,___,___] | Base Rate Loans to be converted to LIBOR Rate Loans with Interest Period of ___ month(s) | |||
$[___,___,___] | LIBOR Rate Loans to be converted to Base Rate Loans |
EXHIBIT A-2-2
$[___,___,___] | LIBOR Rate Loans to be continued with Interest Period of ___ month(s) | |||
$[___,___,___] | Base Rate Loans to be converted to LIBOR Rate Loans with Interest Period of ___ month(s) | |||
$[___,___,___] | LIBOR Rate Loans to be converted to Base Rate Loans |
AURORA DIAGNOSTICS, LLC | ||||
By: | ||||
Name: | ||||
Title: |
EXHIBIT A-2-2
CREDIT AND GUARANTY AGREEMENT
$[1][___,___,___] [2][mm/dd/yy] | New York, New York |
[1] | Lender’s Tranche B Term Loan Commitment | |
[2] | Date of Issuance |
EXHIBIT B-1-1
EXHIBIT B-1-2
AURORA DIAGNOSTICS, LLC | ||||
By: | ||||
Name: | ||||
Title: |
EXHIBIT B-1-3
TRANCHE B TERM NOTE
Amount of | Amount of | Outstanding | ||||||
Loan Made | Principal Paid | Principal | Notation | |||||
Date | This Date | This Date | Balance This Date | Made By | ||||
CREDIT AND GUARANTY AGREEMENT
$[1][___,___,___] [2][mm/dd/yy] | New York, New York |
[1] | Lender’s Revolving Credit Commitment | |
[2] | Date of Issuance |
EXHIBIT B-2-1
EXHIBIT B-2-2
AURORA DIAGNOSTICS, LLC | ||||
By: | ||||
Name: | ||||
Title: |
EXHIBIT B-2-3
REVOLVING LOAN NOTE
Amount of | Amount of | Outstanding | ||||||
Loan Made | Principal Paid | Principal | Notation | |||||
Date | This Date | This Date | Balance This Date | Made By | ||||
CREDIT AND GUARANTY AGREEMENT
$[1][___,___,___] [2][mm/dd/yy] | New York, New York |
[1] | Lender’s Revolving Credit Commitment | |
[2] | Date of Issuance |
EXHIBIT B-2-1
EXHIBIT B-2-2
AURORA DIAGNOSTICS, LLC | ||||
By: | ||||
Name: | ||||
Title: |
EXHIBIT B-2-3
SWING LINE NOTE
Amount of | Amount of | Outstanding | ||||||
Loan Made | Principal Paid | Principal | Notation | |||||
Date | This Date | This Date | Balance This Date | Made By | ||||
EXHIBIT B-2-1
CREDIT AND GUARANTY AGREEMENT
EXHIBIT C-A-1
1 | To be used on annual compliance certificate. | |
2 | To be used on annual compliance certificate. |
EXHIBIT C-A-2
AURORA DIAGNOSTICS HOLDINGS, LLC | ||||
By: | ||||
Title: Chief Financial Officer | ||||
EXHIBIT C-A-1
COMPLIANCE CERTIFICATE
1.Consolidated Adjusted2 EBITDA:(i) — (ii) = | $[___,___,___][___]3[___]4 |
(i) | (a) | Consolidated Net Income: | $[___,___,___] | |||
(b) | Consolidated Interest Expense: | $[___,___,___] | ||||
(c) | Consolidated Tax Expense [*]: | $[___,___,___] | ||||
(d) | total depreciation expense: | $[___,___,___] | ||||
(e) | total amortization expense: | $[___,___,___] | ||||
(f) | other non-Cash items reducing Consolidated Net Income[**]: | $[___,___,___] | ||||
(g) | (1) management fees to Sponsors or any of their Affiliates in the amounts and the times specified in the Management Services Agreement, as in effect on the Closing Date and (2) consulting fees, advisory fees or similar fees to Sponsors or any of its Affiliates pursuant to the terms of the Management Services Agreement, as in effect on the Closing Date | $[___,___,___] | ||||
(h) | costs, fees, expenses, charges, discounts and premiums incurred on the Closing Date in connection with the transactions contemplated by the Credit Documents, including, without limitations, any of the foregoing incurred with respect to Existing Indebtedness, and costs, fees, expenses, charges, discounts and premiums incurred after the Closing Date with respect to any increase in the Revolving Commitment, to any New Revolving Commitment, to any New Term Loan Commitment, or to any amendment, consent, waiver or other modification relating to the Credit Documents | $[___,___,___] |
1 | As adjusted pursuant to Section 6.8(d) of the Credit Agreement. | |
2 | With respect to any period identified on Schedule C-1 of the Credit Agreement, the amount shown on Schedule C-1 as the Consolidated Adjusted EBITDA for that period shall be used herein for all purposes. | |
3 | September 30, 2009 | |
4 | December 31, 2009 | |
[*] | Including Tax Distributions to the extent deducted from Consolidated Net Income. | |
[**] | Excluding any such non-Cash item to the extent that it represents an accrual or reserve for potential Cash items in any future period or amortization of a prepaid Cash item that was paid in a prior period, including, without limitation, any non-cash charge required by GAAP related to changes in the “fair value” of any Earnout Amounts. |
EXHIBIT C-A-2
(i) | costs, fees, expenses, charges, discounts and premiums incurred after the Closing Date in connection with the transactions contemplated by the Credit Documents (whether or not consummated and including Permitted Acquisitions, issuances of Indebtedness, Investments, dispositions of Assets and sales of Capital Stock) in an aggregate amount not to exceed $2,5000,000 in any 12 month period | $[___,___,___] | ||||
(j) | fees and expenses payable to Haverford pursuant to the Consulting Agreement in effect on the Closing Date | $[___,___,___] | ||||
(k) | the cumulative effect of any Accounting Changes described in Section 1.2 of the Credit Agreement and purchase price accounting principles | $[___,___,___] | ||||
(l) | letter of credit fees not to exceed $50,000 in the aggregate in any 12 month period | $[___,___,___] | ||||
(m) | non-recurring, extraordinary or unusual expenses or charges (including non-recurring severance expenses (incurred in connection with a Permitted Acquisition or otherwise), and integration expenses and the amount of any restructuring charge or reserve, in each case incurred in connection with any Permitted Acquisition), in a total aggregate amount not to exceed $5,000,000 in any twelve month period (provided that, amounts in respect of the non-recurring charges described on Schedule A-1 to the Credit Agreement that are added pursuant to this clause (m) shall not be included in the calculation of availability under the $5,000,000 limitation) | $[___,___,___] | ||||
(n) | acquisition related costs expensed pursuant to FASB 141r that would otherwise have been capitalized under GAAP immediately prior to the effectiveness of FASB 141r | $[___,___,___] | ||||
(o) | any one-time expenses relating to enhanced accounting function, or one-time costs and expenses associated with becoming a public company, including expenses incurred in connection with the Reorganization Transactions | $[___,___,___] | ||||
(p) | TRA Distributions (to the extent deducted from Consolidated Net Income) | $[___,___,___] |
EXHIBIT C-A-3
(q) | any out-of-pocket costs or expenses incurred pursuant to the implementation, administration and management of any management equity plan or stock option plan or other management or employee benefit plan or agreement, any management or employee stock-based compensation agreement, or any stock subscription or shareholder agreement in an aggregate amount not to exceed $500,000 in each Fiscal Year | $[___,___,___] | ||||
(r) | any non-Cash expenses resulting from any management equity plan or stock option plan or other management or employee benefit plan or agreement or any stock subscription or shareholder agreement of employees of any Credit Party | $[___,___,___] | ||||
(ii) | (a) | other non-Cash items increasing Consolidated Net Income[**] | $[___,___,___] | |||
(b) | interest income | $[___,___,___] |
2. Consolidated Capital Expenditures: | $[___,___,___] | |||
3. Consolidated Cash Interest Expense: | $[___,___,___] | |||
4. Consolidated Current Assets: | $[___,___,___] | |||
5. Consolidated Current Liabilities: | $[___,___,___] | |||
6. Consolidated Excess Cash Flow:(a) — (b) = | $[___,___,___] |
(a) | (i) | Consolidated Adjusted EBITDA: | $[___,___,___] | |||
(ii) | net increase in Consolidated Current Liabilities | $[___,___,___] | ||||
(iii) | net decrease in Consolidated Current Assets | $[___,___,___] | ||||
(b) | (i) | Consolidated Cash Interest Expense | $[___,___,___] | |||
(ii) | net decrease in Consolidated Current Liabilities | $[___,___,___] | ||||
(iii) | net increase in Consolidated Current Assets | $[___,___,___] | ||||
(iv) | Consolidated Tax Expense (including Tax Distributions to the extent added in the calculation of Consolidated Adjusted EBITDA) | $[___,___,___] |
[**] | Excluding any such non-Cash item to the extent that it represents the reversal of an accrual or reserve for potential Cash item in any prior period. |
EXHIBIT C-A-4
(v) | TRA Distributions | $[___,___,___] | ||||
(vi) | costs, fees, expenses, charges, discounts and premiums incurred after the Closing Date in connection with transactions permitted by the Credit Documents (whether or not consummated and including Permitted Acquisitions, issuances of Indebtedness, Investments, dispositions of Assets and sales of Capital Stock) in an aggregate amount not to exceed $2,500,000 in any 12 month period | $[___,___,___] | ||||
(vii) | any other cash charges, cash expenses, cash losses, or other cash items added to Consolidated Adjusted EBITDA | $[___,___,___] | ||||
(viii) | Consolidated Capital Expenditures made in cash | $[___,___,___] | ||||
(ix) | cash paid for Permitted Acquisitions and other Investments | $[___,___,___] | ||||
(x) | scheduled payments of Indebtedness (including scheduled payments under the Tranche B Term Loan Facility and payments in respect of Earnout Amounts) | $[___,___,___] |
7.Consolidated Interest Expense: | $[___,___,___] | |
8.Consolidated Net Income: (i) — (ii) = | $[___,___,___] |
(i) | the net income (or loss) of Holdings and its Subsidiaries prior to an IPO, and of Public Parent and its Subsidiaries after an IPO, on a consolidated basis for such period taken as a single accounting period determined in conformity with GAAP: | $[___,___,___] | ||||
(ii) | (A) | the income (or loss) of any Person (other than a Subsidiary of Holdings or Public Parent, as applicable) in which any other Person (other than Holdings or any of its Subsidiaries or Public Parent or any of its Subsidiaries, as applicable) has a joint interest, except to the extent of the amount of dividends or other distributions actually paid to Holdings or any of its Subsidiaries by such Person during such period: | $[___,___,___] | |||
(B) | the income (or loss) of any Person accrued prior to the date it becomes a Subsidiary of Holdings or Public Parent, as applicable, or is merged into or consolidated with Holdings or any of its Subsidiaries or Public Parent or any of its Subsidiaries, as applicable, or that Person’s assets are acquired by Holdings or any of its Subsidiaries or by Public Parent or any of its Subsidiaries, as applicable: | $[___,___,___] |
EXHIBIT C-A-5
(C) | the income of any Subsidiary of Holdings or Public Parent, as applicable, to the extent that the declaration or payment of dividends or similar distributions by that Subsidiary of that income is not at the time permitted by operation of the terms of its charter or any agreement, instrument, judgment, decree, order, statute, rule or governmental regulation applicable to that Subsidiary: | $[___,___,___] | ||||
(D) | any after-tax gains or losses attributable to Asset Sales or returned surplus assets of any Pension Plan: | $[___,___,___] | ||||
(E) | to the extent not included in clauses (ii)(A) through (D) above, any net extraordinary gains or net non-cash extraordinary losses: | $[___,___,___] |
9.Consolidated Total Debt: | $[___,___,___] | |
10.Consolidated Total Secured Debt: | $[___,___,___] | |
11.Interest Coverage Ratio:(i)/(ii) = |
(i) | Consolidated Adjusted EBITDA | $[___,___,___] | ||||
(ii) | Consolidated Cash Interest Expense | $[___,___,___] |
Actual: | _.___:1.00 | |||
Required: | _.___:1.00 | |||
12.Leverage Ratio:(i)/(ii) = |
(i) | Consolidated Total Debt | $[___,___,___] | ||
(ii) | Consolidated Adjusted EBITDA7 for the four-Fiscal Quarter period then ended: | $[___,___,___] |
Actual: | _.___:1.00 | |||
Required: | _.___:1.00 | |||
13.Consolidated Capital Expenditures | ||||
Actual: | $[___,___,___] | |||
Permitted: | $[___,___,___] |
1 | As adjusted pursuant to Section 6.8(d) of the Credit Agreement. |
EXHIBIT C-A-6
CREDIT AND GUARANTY AGREEMENT
EXHIBIT D-1
One Atlantic Center
1201 West Peachtree Street
Atlanta, Georgia 30309-3424
Fax: 404-881-7777
www.alston.com
New York, NY 10019
Guaranty Agreement referred to below
as of the date hereof
(a) | the Credit and Guaranty Agreement; | ||
(b) | each of the Notes listed on Schedule 2 attached hereto (the “Notes”); | ||
(c) | the Pledge and Security Agreement; |
Page 2
(d) | the Grant of Security Interest — Trademarks (the “Trademark Security Agreement”) made by Borrower and Cunningham Pathology, L.L.C. in favor of the Collateral Agent; | ||
(e) | the Grant of Security Interest — Copyrights (the “Copyright Security Agreement”) made by Pathology Solutions, LLC in favor of the Collateral Agent; | ||
(f) | each of the Deposit Account Control Agreements listed on Schedule 2 attached hereto (each a “Deposit Account Control Agreement” and together the “Deposit Account Control Agreements”); and | ||
(g) | each of the unfiled financing statements on Form UCC-1 naming an Opinion Party identified as “Debtor” on Schedule 3 attached hereto, as debtor, and the Collateral Agent, as secured party, copies of which are attached hereto as Exhibit A (the “Financing Statements”), to be filed in the office (the “Filing Office”) of the applicable state identified on Schedule 3 attached hereto (the “Filing Jurisdiction”). |
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
Page 10
Page 11
Page 12
Page 13
Page 14
Very truly yours, | ||||||
ALSTON & BIRD LLP | ||||||
By: | /s/ Alston & Bird LLP |
To Opinion of Alston & Bird LLP
BORROWER: | Jurisdiction of Organization | |
Aurora Diagnostics, LLC | Delaware | |
GUARANTORS: | Jurisdiction of Organization | |
Aurora Diagnostics Holdings, LLC | Delaware | |
Laboratory of Dermatopathology ADX, LLC | New York | |
Aurora Michigan, LLC | Michigan | |
Aurora LMC, LLC | Nevada | |
Hardman Pathology ADX, LLC | Georgia | |
Mark & Kambour, LLC | Florida | |
Covenant Healthcare Lab, LLC | Florida | |
Aurora New Hampshire, LLC | New Hampshire | |
Cunningham Pathology, L.L.C. | Delaware | |
Twin Cities Dermatopathology, LLC | Minnesota | |
Aurora Greensboro LLC | North Carolina | |
Aurora Massachusetts, LLC | Delaware | |
Pathology Solutions, LLC | New Jersey | |
Mark & Kambour Holdings, Inc. | Florida | |
Seacoast Pathology, Inc. | New Hampshire | |
C R Collections, LLC | Alabama | |
Greensboro Pathology, LLC | North Carolina | |
Bernhardt Laboratories, Inc. | Florida | |
Opinion Parties | ||
Aurora Diagnostics, LLC | Delaware | |
Aurora Diagnostics Holdings, LLC | Delaware | |
Cunningham Pathology, L.L.C. | Delaware | |
Aurora Greensboro LLC | North Carolina | |
Greensboro Pathology, LLC | North Carolina |
To Opinion of Alston & Bird LLP
To Opinion of Alston & Bird LLP
Debtor | Filing Office | Filing Jurisdiction | ||
Aurora Diagnostics, LLC | Office of the Secretary of State | Delaware | ||
Aurora Diagnostics Holdings, LLC | Office of the Secretary of State | Delaware | ||
Cunningham Pathology, L.L.C. | Office of the Secretary of State | Delaware | ||
Aurora Greensboro LLC | Office of the Secretary of State | North Carolina | ||
Greensboro Pathology, LLC | Office of the Secretary of State | North Carolina |
To Opinion of Alston & Bird LLP
Number of | Certificate | Percentage of | ||||||||||||||||||
Holder | Issuer | Class | Shares/Units | Number | Ownership | |||||||||||||||
Aurora Diagnostics Holdings, LLC | Aurora Diagnostics, LLC | membership interests | 1000 units | C-1 | 100 | % | ||||||||||||||
Aurora Diagnostics, LLC | Aurora Michigan, LLC | membership interests | 1000 units | C-1 | 100 | % | ||||||||||||||
Aurora Diagnostics, LLC | Aurora New Hampshire, LLC | membership interests | 1000 units | C-1 | 100 | % |
To Opinion of Alston & Bird LLP
UCC FINANCING STATEMENT FOLLOW INSTRUCTIONS (front and bank) CAREFULLY A. NAME & PHONE OF CONTACT AT FILER opllonaij Christine Dionne 212-848-4000 B. SEND ACKNOWLEDGMENT TO: (Name and Address) [Shearman & Sterling LLP 599 Lexington Avenue : ; New York, NY 10022-6069 cdionne@shearman.com THE ABOVE SPACE IS FOR FILING OFFICE USE QMLY 1. DEBTOR’S EXACT FULLlEGALNAME.ugBiTQmyainiteMsrna™(1aar1b).donatalibiiH!3teDfi!aifib.ne rams 1a, ORGANIZATION’S NAME — Aurora Diagnostics, LLC OR T briNDWIiXJAl’SLASTNAMEI FIRST NAME I Ml DOLE NAME j SUFFIX 1C. MAILING ADDRESS CITY STATE POSTAL CODE COUNTRY 11025 RCA Center Drive, Suite 300 Palm Beach Gardens FL [33410 US Id. BEE INSTRUCTIONS IADDT.1NFORE 1e.TYPEOFORGANEATIONIt JURISDICTION OF ORGANIZATION 1g. ORGANIZATIONAL ID #, if an/ ORGANIZATION ‘ T T p T\ Jo warp A IT 1 OR 1 n DEBTOR [LiA jLvetawars ftjjuoi \\WXK 2. ftDDlTIQMAL DE BTQR’S EXACT FULL LEGAL NAME . insert only ana debtor name pa or ia). do naiatbtevlata or comlMnB names 2a. ORGANIZATION’S NAME “ 2b. 1HDIVIDUA1.’S LAST NAME I FIRST NAME MCDLENAWE ISUFFIX le. MAILING ADDRESS CTT? ‘ ™” STATE I POSTAL CODE COUNTRY 3d SFglHSTRUCTIONS (ADD’LINPORE 2e TYPEOFORQANEATION 2t. JUHISDICnONeiFOFKaANCftTION “ 2g. ORGANI2ATIONALIDS, ilany ORGANIZATION ___IPEBTOH I I I DNONE 3.SECURED PARTY’S NAME<orNAMEotTOTALASSIGNEEc(A5SISNORaP)-!nEErtoiilyi!nssBi;urai)iHrtyn3ri»C3soi3b) . ORGANEZATIOlfS NAME “ Barclays Bank PLC, as Collateral Agent OR 3D. INDIVIDUAL’S LASTKAME “ I FIRST NAME “ JOODIBTHME [SUFFIX 3d MAILINGADDR6SS OTT STATE POSTAL CODE COUKIRY “ _ 745 Seventh Avenue New York NY 10019 US 4. This FINANCING STATEMENT covera the following collateral: AH assets of the Debtor, whether now owned or hereafter acquired. 5. ALTBWA7JVEDESIGNATiavirifapplfcal>tal:[jLES5EBl.ESSOR QcOHSKSNgE/COHSlGMOR MBAILEaBAILQR MsELLERfBiyVER JA<S. LIEU EjTON-IJCC!Fit.lNO “67rTs?inftSCiNSCTATaiEWi5tnTOS3jorrec5!3n3rreSlf3e5m*?RlAir™Rrch REaOESTSEBRCflREPORT7sT!rBsBo!5rT* TTTTTr™m!rTTTr ESTATE RECORDS Attjicli Addendum H eppicabtel I iADprppl. FEE fodJonin LJ A3 ttebtas LJPebtor 1 LJPaKm 2 &.OFTIONA1. FILER REFHIEUCE E»TA FS276828 Filed with: DE — Secretary of State ZUN09695 FILING OFFJOE COPY — UCC FINANCING STATEMENT (FORM UCC1) (REV. 05/22/02) |
UCC FINANCING STATEMENT FOLLOW INSTRUCTIONS (Front end back) CAREFULLY A. NAME 1 PHONE OF CONTACT AT FILER [optlonalf Christine Dionne 212-848-4000 B. SEND ACKNOWLEDGMENT TO; (Name and Address) [Shearman & Sterling LLP 599 Lexington Avenue New York, NY 10022-6069 [cdionne@shearman.com ___-_«___THE ABOVE SPACE IS FOR FILING OFFICE USE ONLY 1. DEBTOR’SEXACTFlJLLLESALHAME-inseitiiiilyiiiadabloinaniBdaorlbl.donotabbrailattiofsoiTibinBnaniei la. ORGANIZATION’S NAME — Aurora Diagnostics Holdings, LLC OR 1b. INOSVIDUAUSLAST NAME [FIRST NAME “ I MIDDLE NAME JSUFFIX 1c MAILING ADDRESS CITY STATE I POSTAL CODE COUNTRY 11025 RCA Center Drive, Suite 300 Palm Beach Gardens FL J33410 US 1d. SEEJMSTRUCTIOHS I ADD! WTO RE llaTYPEOFORGANUIATIONIf. JURISDICTIONOF ORGANIZATION1g ORGANIZATIONAL ID#, if any giLLC (Delaware 162777 p 2. ADDITIONAL DEBTOR’S EXACT FULL LEGAL NAME — ins«l only gos debtor nairm (2a «2>) — tenombbnvlaia mamftiaa names 29. ORGANIZATION’S NAME “ OR Zb. INDIVIDUAL’S LAST NAME F!RSTNAMI JMICCLE NAME ISUFFIX 2d MAILING ADDRESS OIY ‘ ™ STATE IPO5TW.CQCE COUNTRY ad SEEIHBTHUCTIOHS fADDltNFORE 12e TYPE OF ORGANIZATION 2f! JURISDICTION OFORGANIZATON 2g. ORSiWlZATlONAL ID ft if any ORGANIZATION ,, JDEBTOR ] riNONE 3.SECURED PARTY’SNAlylE(orNAMEo»TUFALABSI6HEEofA5SH3NORSJP).insertnnVi;aaseciired >artynaiiiet3aorab) ___3a ORSANEATION’S NAME Barclays Bank PLC, as Collateral Agent OR 3b. INDIVIDUAL’S LAST NAME IFIRSTNAME j Ml DOLE NAME ISUFFK 3e. MAILING ADDRESS Cfff ‘ STWE IPOSTM. CODE OOWRS? ___745 Seventh Avenue New York NY 10019 US 4.This FINANCING STATEMENTciwsBlheJelkiwIngcollaterBi: All assets of the Debtor, whether now owned or hereafter acquired. 5. AVTERNATIVE OESiSNATION [if 3ppikableiriLESSEE/I.ESSOR MCOMSISNEBCONSIQNOR riaAlLgE/BAa.OR nSELLEFireUYER [J AG. lENI [jNOM-UCCFIUNe “eTn’isRNA’*’3 sTAfaHEMTfe to SBfliein5rffico!5TorTs™i3S3ri!!o!eBE7!i—FTTSKonoBSajfesr SEARCH REFRWo!TD7ES;j5yTT’T”™™“M *v™™™Tlr™” I ESTATE RECOUPS. AEaeh AdJ«nitur;i nucniabfal I rAOOITIOMAUEEl locOcnan LjAIIDeblnra LlDeMorl L O«blQr2 8. OPTIONAL FILER REFERENCE DATA FI276829 Filed with: DE — Secretary of State A8409636 FIUNQ OFFICE COPY — UCC FINANCING STATEMENT (FORM UCC1) (REV. 05/22D2) |
UCC FINANCING STATEMENT FOLLOW INSTRUCTIONS (fmnl and back) CAREFULLY A. NAME & PHONE OF CONTACT AT FILER [optional] Christine Dionne 212-848-4000 B. SEND ACKNOWLEDGMENT TO: (Name and Address) ‘ [shearman & Sterl ing LLP 599 Lexington Avenue New York, NY 10022-6069 [cdionne@shearman.com THE ABOVE SPACE IB FOR PILING OFFICE USE ONLY 1. DEBTD R’S EXACT FULL LEGAL NAME-lnsertonlygis debtor name tlaoilb)- donrfabtievlate a combine names la ORGANIZATION’S NAME Cunningham Pathology, L.L.C. OR 1 1 1 1• 1 UK Ib, INDSVJDUAL’SLASTNAME .=1RSTNAME MUDDLE NAME SUFFIX 1C, MAILING AOOSB5S CITY STATE I POSTAL CODE COUNTRY 11025 RCA Center Drive, Suite 300 Palm Beach Gardens FL 33410 US Id SEEIMSTCDCnOHS lADffLINFORE Me. TYPE OF ORGANIZATIONIf. JURISDICTIONQFQRSANIZATICN Ifl. ORSANiZATlONAL IDS, il any gr” LLC pelamre ,2977484 Q 2. ADDITIONAL DEBTOR’S EXACT FULL LEGAL NAME — Ireeit only eaedeblni name ga a 2b). do nol abbreviate or combine names ___2a. ORGAMIZAT1OM-S NAME OR 2b. INDIVIDUAL’S LAST NAME I FIRST NAME j MUDDLE WME I SUFFIX 2e. MAIUNG ADDRESS CTTY ™ STATTf [POSTAL CODE COUrftRY 3d. SEEIHSTRUCTIOMa IADCTLINFORE 129. TYPEOF ORGANIZATION 2f. JUFHSDBtlCN OF CRQANKAT1ON 29. ORGANIZATIONAL ID #. if any OReWMEATION ___IPEBTOR j I I HHCINE 3.5ECUREDPARTY’SME(orHAMEplTOTALASSieNEEolAMieTORS.hsertCTl>‘angeecurpanVBameg 39. ORSANIZflTfON’SKAMe Barclays Bank PLC, as Collateral Agent OR 3b. INDIVIDUAL’S LAST NflME ‘ I FIRST NAME IMIDDLE NAME I SUFFIX 3t MAIUNB ADDRESS OTY ‘ STATE” [POSTAL CODE COUNTRY . 745 Seventh Avenue New York NY 10019 US 4. Tttte FINANCING STATEMENT corers ftefollowing collateral: AH assets of the Debtor, whether now owned or hereafter acquired. 5. ALTERNATIVE DESIGNATIONTtfappliCTblBlOLESSeBLESSOR MCONBISNEEfCONBICNOR riBAILESBAILOR jELLgRyBURrjAG LIEH riMOH-tlCCFILINe 6. nilsFlKlANCINQEtAlaiflENTlltobffilH loi’OKWtflffmsmliQin“8»REAL “T7TcTrecTloRE38ECTSA5!?P5RTMoirtoMoPT“r*™™™“n.™TTT!1 L-lESTATei?6ca3RPS. Attach Mfendmn Hf applieabteT I JyJDDmONALFEEl lopfonail LJ All Deblms [ ICebtel I. JPeMDj2 8. OPTIONAL FILER REFERENCE DATA F#276630 Fi led with: DE - Secretary of State A# 4 0 9 6 97 FILING OFFICE COPY — UCC FINANCING STATEMENT (FORM UCC1) (REV. 05f2J/OZ) |
UCC FINANCING STATEMENT FOLLOW MBTHUgnoMS (front and back) CAREFULLY A. NAME A PHONE OF CONTACT AT FILER [optional] Christine Dionne 212-848-4000 B. SEND ACKNOWLEDGMENT TO: (Name and Addfess) ishearman & Sterling LLP 599 Lexington Avenue New York, NY 10022-6069 [cdionne@shearman,com ——w _—___THE ftBOVE SPACE IS FOR FILIHC OFFICE USE OMLY 1. DEBTOR’S EXACTFULL LEGAL NAME. iHeityane<<gbterriame(1aCTlbfer.atabiBaaite 01 wmblna names la. ORGANIZATOW5 NAME Aurora Greensboro LLC OR tb. INDIVIDUAL’S LASTNAMEI FIRST NAME I MIDDLE NAME I SUFFIX 1c. MAILING ADDRESS CtTY STATE I POSTAL COPE COUNTRY 11025 RCA Center Drive, Suite 300 Palm Beach Gardens JFL [33410 JUS Id. SEE INSTRUCTIONJACKJLINFORE 11e. TYPE CF ORGANIZATION” 1f. JURISDICTIONOF ORGANIZATION J1g OROAHEAT1ONA-. IDS. It any farlLLC JNorth Carolina ,1002834 CW 2. ADDITIONAL DEBTOR’S EXACT FULL LEGAL NAME• InsK-.orilyeaa debtor name pa or2b)• dp naabbiBviate or combine names 29- ORGANIZATION’S MANSE OR 2b, INDIVDUAL’S LAST NAME IFIRSINAKE IMIDOLENAME 1 SUFFIX ZC. MAIUNG ADDRESS OTV STATE I POSTAL OOOE COUNTRY Zd SEEIMSTRUCTiOHS I ADffL INFO RE lle.TYPEOF ORGANIZATION 2f. JURISDICTION OFORGANiZATIQN fl. ORGANIZATIONAL ID #. if any ORGANIZATION ___loEeTOR f rlNONE 3.SECUREDPARTVSNAMB(orNAMEoITOrALASSieNE6DlASSK3NORS;fl.jiBHlon]yBnflsecuredp!irtyjratnapaw3b} 3a. ORGANIZATSOM’S NAME Barclays Bank PLC, as Collateral Agent OR 3t>. INDIVDUAL’S LAST NAME ‘ IFlRSTNAME ‘ jMIDDLE NAME [SUFFIX So. MAILINGADDR6SS CITY STATE FESTAL CODE COUMTRY — 745 Seventh Avenue New York NY 10019 US 4. This FINANCING STATEMENT covers (tiefollowing collateral: All assets of the Debtor, whether now owned or hereafter acquired. 5. ALTERNATIVE DESIGNATION lit applJcab!e]:C l 6SSEEfLESSOR JcONaGNEBCQNSK3NOR DBAILEE/BAlLOR ___f] SELLERfBUYR 7JAG. LIENI FlNOH-UroFILINQ npn*Is?lMNiKnlNnobe?ileTO.rffcS™Twor3eDn’rRlSAL“wT7P5to” “llTlr LJ ESTATE RECORDS. Aaach AddMriui, ‘.’ Jif spplicaMa] \ pipDrOflALfEEl _. .1_1_ [opfoniill AII DeByraJJogtorlJPebtorZ B. OPTIONAL FILER REFERENCE DATA Ff 27 68 9 4 Filed with: NC — Secretary of State A#4097ll FILINO OFFICE COPY— UCC FINANCING STATEMENT (FORM UCC1) (REV. 05/22/02) |
UCC FINANCING STATEMENT FOLLOW INSTRUCTIONS (Irani and back) CAREFULLY A. NAME & PHONE OF CONTACT AT FILER [optional] Christine Dionne 212-548-4000 B.SSND ACKNOWLEDGMENT TO: (Nama and Address) (Shearman & Sterling LLP 599 Lexington Avenue New York, NY 10022-6069 [cdionne@sheannan.com THE flBOVE SPACE IS FOR FIUNC OFFICE USE OHLY 1. DEBTOR’S EXACT FULLLEGAL WME- inse.-tQnlysmadablprnarne (la a 1b)-<lD notabbreviateorcoipbint mines 1a. ORGANIZATION’S NAME — Greensboro Pathology, LLC CR 1b. INDIVIDUALS LAST NAME I FIRST NAME ‘ tMTO’,E NAME [SUFFIX 1C MAILING ADDRESS GTTY “™’ StfiTS I POSTAL CODE COUNTRY 11025 RCA Center Drive, Suite 300 Palm Beach Gardens JFL 33410 US Id. SEElMSTaUCJIQMS lADDllNFORE lle.TfPE OF ORGANIZATION1f. JURI3D.CT1ON OF ORGANIZATION13. ORGANIZATIONAL IDS, If any IgoTlLLC orth Carolina ,0062894 pE 2. ADDITIONAL DEBTOR’S EXACT FULL LEGAL NAME - hunt only B3£ debtor nama pa pi ;b) — do no! alibrniateoi mmMnB namiia 2a. ORGANIZATION’S NAWE CR 2b. INDIVIDUAL’S LAST HM.K IFWSTNAHE I MIDDLE NAME (SUFFIX ZG. MAILING ADDRESS CifP STATE [ POSTAL CODE COUM7RY M. S=EI»KTR(ICT!OMS j ADiyU INFO RE 12e. TYPE OF ORGANIZATION 31. JURISOJCTION OFCRGANtZATION Zg OROAmZA-nOHflLIDS.Kany ORSANEATiON _. IDESTOR — UNCHE 3. SECURED PARTYS NAME (otNAMEnfTOTALASSIGNEgof ASSIGNOR SP)-h5ertonlflMKKUied partn»mB(3aor3b) 3a. ORGANEATIOM’S NAME Barclays Bank PLC, as Collateral Agent OR 3b. INDiVCOAL’S LAST NAME “ I FIRST NAME JMIDDLE KAME pUFFJX 30 MAILING ADDRESS CTY STATE JPOSTALCODE COUHIIW ___745 Seventh Avenue New York NY 10019 US 4. Tills FINANCING STATEMENT coven ttw fcBcwing collateral: All assets of the Debtor, whether now owned or hereafter acquired. 5. ALTERNATIVEPESIGHA71ON(if aptfiaMe]:nt.ESSEBLESBQR QCONSISNEBCOHSieNOR flBAILEE/BAILOR nSELLaWUYER J]AG UEH lJNCTI-tJCCFILINS g™!”!15 FINAPK;iNtj tEMEMT is loDafMeaite noonSI for recoitietf) wi ttre REAL I 7. CheciTlo REQUEST SEARCH REPORTfsTcnDeEtonErr L fir, \ I ESTATE RECORDS, Atoch Addenrfum Trf 3Dp1icaM6l I rAOPrrfOHAL FFF _loptiDoaH (___A3 Dolitore F loeblof 1 I DebE&rg B. OPTIONAL FILER REFERENCE DATA Fjt 27 68 4 5 Filed with: NC — Secretary of State R# 4 o 9712 RUNG OFFICE COPY — UCC FINANCING STATEMENT (FORM UCC1) (REV. 05(22/02) |
Attorneys at Law
Collateral Agent under the Credit Agreement referred
to below and the Lenders party thereto
Re: | Aurora Diagnostics, LLC Senior Secured Credit Facilities |
May 26, 2010
Page 2 of 11
Attorneys at Law
May 26, 2010
Page 3 of 11
1. | Copies of each of the Articles of Organization of M&K LLC, the Articles of Incorporation of M&K Holdings, and the Amended and Restated Articles of Incorporation of Bernhardt (collectively, the “Articles”), in each case attached to the Certificate of the Secretary of M&K LLC, M&K Holdings and Bernhardt, respectively, and in each case dated as of May 26, 2010 (collectively, the “Secretary’s Certificates”); | ||
2. | Copies of each of the Operating Agreement of M&K LLC, the Bylaws of M&K Holdings, and the Amended and Restated Bylaws of Bernhardt (collectively, the “Bylaws” and together with the Articles, the “Charter Documents”), in each case attached to the applicable Florida Guarantor’s Secretary’s Certificate; | ||
3. | Certificate of Status of each of M&K LLC, M&K Holdings and Bernhardt issued by the Office of the Secretary of State of Florida on May 18, 2010 in the case of M&K LLC and M&K Holdings, and on May 19, 2010 in the case of Bernhardt (collectively, the “Florida Certificates of Status”); | ||
4. | Limited liability company resolutions of the members of M&K LLC and corporate resolutions of each of M&K Holdings and Bernhardt (collectively, the “Transaction Resolutions”) that are in each case attached to the applicable Florida Guarantor’s Secretary’s Certificate; | ||
5. | Incumbency Certificate of each of the Florida Guarantors which forms a part of the respective Florida Guarantor’s Secretary’s Certificate; and | ||
6. | Officer’s Certificate of each of the Florida Guarantors, each dated as of May 26, 2010 and each delivered to this firm (the “Officer’s Certificates”). |
Attorneys at Law
May 26, 2010
Page 4 of 11
Attorneys at Law
May 26, 2010
Page 5 of 11
i. | None of the execution, the delivery or the performance of the Credit Documents by any such party will result in any violation of or be in conflict with or constitute a default under the charter, bylaws or other organizational or other governing documents of such party, or any agreement, document or instrument to which such party is a party, or any law or governmental rule or regulation applicable to such party; | ||
ii. | No such party is, nor will the execution of any of the Credit Documents cause any party to be, in violation of any order, judgment or decree of any court, arbitration or governmental authority, the consequences of which violation would affect the Credit Documents; and | ||
iii. | Such party is not subject to any special laws, regulations or other restrictions that are not generally applicable to parties participating in transactions of the type contemplated by the Credit Documents; |
Attorneys at Law
May 26, 2010
Page 6 of 11
Attorneys at Law
May 26, 2010
Page 7 of 11
Attorneys at Law
May 26, 2010
Page 8 of 11
Attorneys at Law
May 26, 2010
Page 9 of 11
Attorneys at Law
May 26, 2010
Page 10 of 11
Attorneys at Law
May 26, 2010
Page 11 of 11
Very truly yours, | ||||
/s/ Gunster, Yoakley & Stewart, P.A. | ||||
Gunster, Yoakley & Stewart, P.A. | ||||
Attorneys at Law
as Administrative Agent
and Collateral Agent
745 Seventh Avenue
New York, NY 10019
Guaranty Agreement referred to below
as of the date of this letter
(a) | the Credit and Guaranty Agreement; | ||
(b) | the Pledge and Security Agreement; and | ||
(c) | Deposit Account Control Agreement dated May 26, 2010, between Bank of America, N.A., Collateral Agent, Borrower, the Opinion Party, and certain other affiliates of Borrower. |
2
3
4
Very truly yours, WARNER NORCROSS & JUDD LLP | ||||
By: | /s/ Bruce C. Young | |||
Bruce C. Young, a Partner | ||||
5
UCC FINANCING STATEMENT FOLLOW IM STRUCT! ON £ (trunl and bask’, CARErULLT A. I’.AUi i PHO,\E OF CCTACT ST FIL=R [optional] Christine Dionne 212-848000 G. SEND ACKNOWLEDGMENT TO: (Name and Address) [Shearman & Sterling LLP 599 Lexington Avenue New York, NY 10022-6069 [cdionne@sheannan.com ___THE ABOVE SPACE 15 FOR FILIH6 Of FiC-S USE ONLV 1 3 F ET 0 3 ‘S EXAC T F U -I L E SAL NAME. iirjnmyaa itolim name (la «lt . dn nnnMimlm noma» rorrnt 11. OJWANIWnOWS NAME — Aurora Michigan, LLC OT 1 b.JNDWOUUU.’SLAgrrttMEJFWSTNAM5iMIDOlcNAMtpUFFK 1c. MAIUNGAnoPESS COYSTATE POSTAL CODE COUPTRY 11025 RCA Center Drive, Suite 300 Palm Beach Gardens FL 33410 US Id grqEISTRUeTIOMS IA001 INFO R£ [’• s. TYPE OF ORGANFZATfQN II. JURISfJiCllONOP gHUANlzTlCM t;kt.l/iTKJNAL lu*. flany lagirjLLC .Michigan D1Q92P fW 2. ADJTIONAL EBTOK’5 EXACT FULL LEGAL MAME - msgrtonty arj chrtter rjjn> {S or 2tO p not jbbfgmjto of twnblr* ninat 7i OA£AN£ATiarr£NAM£ 2lK INCKVIOUAL’fi LAST NAME FRSfMJtMS IWDDLEMttrtE JfTx iM>i.’lNC>DbRE&s crfr ; STATE QSIAL ua:?i- CDUMTRV -Ja SEEIHtTRUCTIONS [ADCfLINFOSE 2o.TYf>cOFOR5ANC«Km a.JUSISDKT1OHOFOfWANEHTKJH !g.“6RG«MIZiTOM*L ID«. 1’jSi’ OKGAN1ZAT1ON ___?-’: jj; .- 3. SECORF.D PARTY’S NAME imaAnsmTUT 1L ASSIGHEEaASafiMCItilP)-irEjn«J(aBC«iajaafanynam«(3jnib] 3B. UHUAIAIIUN1 NAVI: Barclays Bank PLC, as Collateral Agent 0” Hi. KDWIDUAL-S USTHAME IBRSTNAMS JMCCLE NAME tsuffK 3t. MWUNOADDRESS CTTY StATl I POSTAL CODE COUrVTRT ___745 Seventh Avenue JNew York NY 110019 US 4.tU»FIHANCV4C STATEMEhTT cok-c:-. L-c FcCiwng cnllahiJal: AN assets of the Debtor, whether now owned or hereafter acquired. ElALTEfiNATiViE DESirJ NATION T.f apHiCJblel d LESSEB’LEilSOft ] Mr»aEE CmSIGNOn5ABffiAHnf>m. L i: H’ELUYIR []ftB. LIES QHQN .l*CC FILhtJC ‘LJeSTTgRECOPf’1- ‘•"•:• ;—•-•]!-. “ ‘ ‘ fM’nitr-hrnbl! I ‘ rDriOHAl. FEE1 ‘ rpi)iii _3___[___AIID<ban, \ IDcbhMjJiJcMai S. DPIONAL FILEK HEFtKiNCE CAtA Ftt27G333 Filed with: MI — Secretary of State M409700 FILING OFFICE CWY — UCC FIWANC3MG STATEMENT (FORM UCC1) (R£Vr 05/22/02) |
7
LIONEL SAWYER & COLLINS ATTORNEYS AT LAW SAMUEL S. LIONEL ALLEN J. WILT 1700 BANK OF AMERICA PLAZA MICHAEL D. KNOX KETAN D. BHIRUD GRANT SAWYER LYNN S. FULSTONE 300 SOUTH FOURTH STREET ERIN FLYNN LAUREN D. CALVERT-ARNOLD (1918-1996) RORY J. REID LAS VEGAS, NEVADA 89101 JENNIFER ROBERTS ROBERT W. HERNQUIST JON R. COLLINS DAN C. McGUIRE (702) 383-8888 MEREDITH L. MARKWELL CHRISTIAN HALE (1923-1987) JOHN E. DAWSON –––– DOUGLAS A. CANNON TIMOTHY R. MULLINER RICHARD H. BRYAN FRED D. “PETE” GIBSON, III FAX (702) 383-8845 RICHARD T. CUNNINGHAM COURTNEY MILLER O’MARA JEFFREY P. ZUCKER CHARLES H. McCREA JR. lsc@lionelsawyer.com MATTHEW R. POLICASTRO BRIAN H. SCHUSTERMAN PAUL R. HEJMANOWSKI GREGORY E. SMITH www.lionelsawyer.com JENNIFER J. DiMARZIO MOHAMED A. IQBAL, JR. ROBERT D. FAISS MALANI L. KOTCHKA PEARL L.GALLAGHER KELLY R. KICHLINE DAVID N. FREDERICK LESLIE BRYAN HART CHRISTINE D. SMITH MARK J. GARDBERG RODNEY M. JEAN CRAIG E. ETEM SUSAN L. MYERS ELIZABETH A. HIGH HARVEY WHITTEMORE TODD E. KENNEDY BRIAN S. PICK JAMES B. GIBSON TODD TOUTON MATTHEW E. WATSON JENNIFER L. BRASTER GREG J. CARLSON CAM FERENBACH JOHN M. NAYLOR LUCAS J. TUCKER ABIGAYLE F. DANG LYNDA S. MABRY WILLIAM J. McKEAN CHRISTOPHER WALTHER JING ZHAO MARK H. GOLDSTEIN ELIZABETH BRICKFIELD KEVIN J. HEJMANOWSKI JOHN D. TENNERT KIRBY J. SMITH GREGORY R. GEMIGNANI COLLEEN A. DOLAN LINDA M. BULLEN JENNIFER A. SMITH LAURA J. THALACKER DAN R. REASER DOREEN SPEARS HARTWELL PAUL E. LARSEN LAURA K. GRANIER MAXIMILIANO D. COUVILLIER III |
May 26, 2010 OF COUNSEL A. WILLIAM MAUPIN RICHARD J. MORGAN* ELLEN WHITTEMORE CHRISTOPHER MATHEWS MARK A. CLAYTON *ADMITTED IN CA ONLY WRITER’S DIRECT DIAL NUMBER(702) 383-8837mgoldstein@lionelsawyer.com |
Credit Agreement referred to below
ATTORNEYS AT LAW
Credit Agreement
May 26, 2010
Page 2
ATTORNEYS AT LAW
Credit Agreement
May 26, 2010
Page 3
ATTORNEYS AT LAW
Credit Agreement
May 26, 2010
Page 4
�� | ||||
Very truly yours, | ||||
/s/ Lionel Sawyer & Collins | ||||
Lionel Sawyer & Collins | ||||
CREDIT AND GUARANTY AGREEMENT
1. | Assignor: | |||
2. | Assignee: | [and is an Affiliate/Eligible Assignee[*****]] | ||
3. | Borrower(s): | |||
4. | Administrative Agent: | Barclays Bank PLC, as the administrative agent under the Credit Agreement | ||
5. | Credit Agreement: | The $335,000,000 Credit and Guaranty Agreement dated as of ___ among Aurora Diagnostics, LLC, a Delaware limited liability company (“Borrower”), Aurora Diagnostics Holdings, LLC, a Delaware limited liability company (“Holdings”), certain subsidiaries of Borrower identified on the signature pages to the Credit |
[****] | For use with an assignment of Revolving Commitments occurring prior to February [___], 2011. | |
[*****] | Select as applicable. |
EXHIBIT E-1
Agreement as Guarantors, the Lenders parties thereto, Barclays Bank PLC, as Administrative Agent and Collateral Agent, and the other agents parties thereto. | ||||
6. | Assigned Interest: |
EXHIBIT E-2
Aggregate Amount | Percentage | |||||
of | Amount of | Assigned of | ||||
Commitment/Loans | Commitment/Loans | Commitment/Loans | ||||
Facility Assigned | for all Lenders | Assigned | [******] | |||
[*******] | $ | $ | % | |||
$ | $ | % | ||||
$ | $ | % |
[NAME OF ASSIGNOR] | [NAME OF ASSIGNEE] | |||||||||
Notices: | Notices: | |||||||||
Attention: | Attention: | |||||||||
Telecopier: | Telecopier: | |||||||||
with a copy to: | with a copy to: | |||||||||
Attention: | Attention: | |||||||||
Telecopier: | Telecopier: | |||||||||
Wire Instructions: | Wire Instructions: |
[******] | Set forth, to at least 9 decimals, as a percentage of the Commitment/Loans of all Lenders thereunder. | |
[*******] | Fill in the appropriate terminology for the types of facilities under the Credit Agreement that are being assigned under this Assignment (e.g. “Revolving Loan Commitment”, “Term Loan Commitment”, etc.) |
EXHIBIT E-3
ASSIGNOR [NAME OF ASSIGNOR] | ||||
By: | ||||
Title: | ||||
ASSIGNEE [NAME OF ASSIGNEE] | ||||
By: | ||||
Title: | ||||
[Consented to and][********] Accepted: BARCLAYS BANK PLC, as Administrative Agent | ||||
By: | ||||
Title: | ||||
[Consented to:][*********] AURORA DIAGNOSTICS, LLC | ||||
By: | ||||
Title: | ||||
[Consented to:][***] [ ], as Issuing Bank and Swing Line Lender | ||||
By: | ||||
Title: | ||||
[********] | To be added only if the consent of the Administrative Agent is required by the terms of the Credit Agreement. | |
[*********] | To be added only if the consent of the Borrower is required by the terms of the Credit Agreement. | |
[***] | To be added only if the consent of the Issuing Bank and Swing Line Lender is required by the terms of the Credit Agreement. |
EXHIBIT E-4
AND ASSUMPTION AGREEMENT
1. | Representations and Warranties. |
1.1 | Assignor. The Assignor (a) represents and warrants that (i) it is the legal and beneficial owner of the Assigned Interest, (ii) the Assigned Interest is free and clear of any lien, encumbrance or other adverse claim and (iii) it has full power and authority, and has taken all action necessary, to execute and deliver this Assignment and to consummate the transactions contemplated hereby; and (b) assumes no responsibility with respect to (i) any statements, warranties or representations made in or in connection with any Credit Document, (ii) the execution, legality, validity, enforceability, genuineness, sufficiency or value of the Credit Agreement or any other instrument or document delivered pursuant thereto, other than this Assignment (herein collectively the “Credit Documents”), or any collateral thereunder, (iii) the financial condition of the Borrower, any of its Subsidiaries or Affiliates or any other Person obligated in respect of any Credit Document or (iv) the performance or observance by the Borrower, any of its Subsidiaries or Affiliates or any other Person of any of their respective obligations under any Credit Document. | ||
1.2 | Assignee. The Assignee (a) represents and warrants that (i) it has full power and authority, and has taken all action necessary, to execute and deliver this Assignment and to consummate the transactions contemplated hereby and to become a Lender under the Credit Agreement, (ii) it meets all requirements of an Eligible Assignee under the Credit Agreement, (iii) from and after the Effective Date, it shall be bound by the provisions of the Credit Agreement and, to the extent of the Assigned Interest, shall have the obligations of a Lender thereunder, (iv) it has received a copy of the Credit Agreement and such other documents and information as it has deemed appropriate to make its own credit analysis and decision to enter into this Assignment and to purchase the Assigned Interest on the basis of which it has made such analysis and decision, and (v) if it is a Non-US Lender, attached to the Assignment is any documentation required to be delivered by it pursuant to the terms of the Credit Agreement, duly completed and executed by the Assignee; and (b) agrees that (i) it will, independently and without reliance on the Administrative Agent, the Assignor or any other Lender, and based on such documents and information as it shall deem appropriate at that time, continue to make its own credit decisions in taking or not taking action under the Credit Documents, and (ii) it will perform in accordance with their terms all of the obligations which by the terms of the Credit Documents are required to be performed by it as a Lender. |
ANNEX-1
2. | From and after the Effective Date, the Administrative Agent shall make all payments in respect of the Assigned Interest (including payments of principal, interest, fees and other amounts) to the Assignor for amounts which have accrued to but excluding the Effective Date and to the Assignee for amounts which have accrued from and after the Effective Date. |
3. | General Provisions. This Assignment shall be binding upon, and inure to the benefit of, the parties hereto and their respective successors and permitted assigns. This Assignment may be executed in any number of counterparts, which together shall constitute one instrument. Delivery of an executed counterpart of a signature page of this Assignment by telecopy, Adobe pdf file or other electronic transmission shall be effective as delivery of a manually executed counterpart of this Assignment. This Assignment shall be governed by, and construed in accordance with, the internal laws of the State of New York without regard to conflict of laws principles (other than Sections 5-1401 and 5-1402 of the New York General Obligations Law) thereof. |
ANNEX-2
CREDIT AND GUARANTY AGREEMENT
EXHIBIT F-1-1
[AURORA DIAGNOSTICS, LLC] | ||||
Title: | ||||
GUARANTORS: [AURORA DIAGNOSTICS HOLDINGS, LLC HARDMAN PATHOLOGY ADX, LLC LABORATORY OF DERMATOPATHOLOGY ADX, LLC TWIN CITIES DERMATOPATHOLOGY, LLC AURORA MASSACHUSETTS, LLC PATHOLOGY SOLUTIONS, LLC AURORA NEW HAMPSHIRE, LLC BERNHARDT LABORATORIES, INC. AURORA MICHIGAN, LLC C R COLLECTIONS, LLC CUNNINGHAM PATHOLOGY, L.L.C. SEACOAST PATHOLOGY, INC. AURORA GREENSBORO LLC MARK & KAMBOUR, LLC MARK & KAMBOUR HOLDINGS, INC. GREENSBORO PATHOLOGY, LLC AURORA LMC, LLC COVENANT HEALTHCARE LAB, LLC] | ||||
Title: |
EXHIBIT F-1-2
CREDIT AND GUARANTY AGREEMENT
EXHIBIT F-2-1
AURORA DIAGNOSTICS HOLDINGS, LLC | ||||
Title: Chief Financial Officer | ||||
EXHIBIT F-2-2
CREDIT AND GUARANTY AGREEMENT
EXHIBIT G-1
EXHIBIT G-2
EXHIBIT G-3
[NAME OF SUBSIDIARY] | ||||
By: | ||||
Name: | ||||
Title: | ||||
Attention:
Telecopier
Attention:
Telecopier
ACKNOWLEDGED AND ACCEPTED, as of the date above first written: BARCLAYS BANK PLC, as Administrative Agent and Collateral Agent | ||||
By: | ||||
Name: | ||||
Title: |
EXHIBIT G-4
CREDIT AND GUARANTY AGREEMENT
TO CREDIT AND GUARANTY AGREEMENT
CREDIT AND GUARANTY AGREEMENT
Page | ||||
SECTION 1. DEFINITIONS; GRANT OF SECURITY | 1 | |||
1.1 General Definitions | 1 | |||
1.2 Definitions; Interpretation | 7 | |||
SECTION 2. GRANT OF SECURITY | 8 | |||
2.1 Grant of Security | 8 | |||
2.2 Certain Limited Exclusions | 9 | |||
SECTION 3. SECURITY FOR OBLIGATIONS; GRANTORS REMAIN LIABLE | 10 | |||
3.1 Security for Obligations | 10 | |||
3.2 Continuing Liability Under Collateral | 11 | |||
SECTION 4. REPRESENTATIONS AND WARRANTIES AND COVENANTS | 11 | |||
4.1 Generally | 11 | |||
4.2 Equipment and Inventory | 14 | |||
4.3 Receivables | 15 | |||
4.4 Investment Related Property | 18 | |||
4.5 Material Contracts | 25 | |||
4.6 Letter of Credit Rights | 26 | |||
4.7 Intellectual Property | 26 | |||
4.8 Commercial Tort Claims | 30 | |||
SECTION 5. ACCESS; RIGHT OF INSPECTION AND FURTHER ASSURANCES; ADDITIONAL GRANTORS | 31 | |||
5.1 Access; Right of Inspection | 31 | |||
5.2 Further Assurances | 31 | |||
5.3 Additional Grantors | 32 | |||
SECTION 6. COLLATERAL AGENT APPOINTED ATTORNEY-IN-FACT | 32 | |||
6.1 Power of Attorney | 32 | |||
6.2 No Duty on the Part of Collateral Agent or Secured Parties | 34 | |||
SECTION 7. REMEDIES | 34 | |||
7.1 Generally | 34 | |||
7.2 Application of Proceeds | 36 | |||
7.3 Sales on Credit | 36 | |||
7.4 Deposit Accounts | 36 | |||
7.5 Investment Related Property | 36 | |||
7.6 Intellectual Property | 37 | |||
7.7 Cash Proceeds | 38 |
- i -
Page | ||||
SECTION 8. COLLATERAL AGENT | 39 | |||
SECTION 9. CONTINUING SECURITY INTEREST; TRANSFER OF LOANS | 39 | |||
SECTION 10. STANDARD OF CARE; COLLATERAL AGENT MAY PERFORM | 40 | |||
SECTION 11. MISCELLANEOUS | 40 |
- ii -
- 2 -
- 3 -
- 4 -
- 5 -
- 6 -
- 7 -
- 8 -
- 9 -
- 10 -
- 11 -
- 12 -
(A) | except for the security interest created by this Agreement, it shall not create or suffer to exist any material Lien upon or with respect to any of the Collateral, except Permitted Liens, and such Grantor shall (1) use commercially reasonable efforts to defend the Collateral against all Persons at any time claiming any interest therein (except Permitted Liens) and (2) notify the Collateral Agent in writing, promptly upon such Grantor obtaining knowledge of the creation or existence of any such material Lien; | ||
(B) | it shall not produce, use or permit any Collateral to be used unlawfully or in violation of any provision of this Agreement or any applicable statute, regulation or ordinance or any policy of insurance covering the Collateral to the extent that non-compliance with such statute, regulation, ordinance or insurance policy could reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect; | ||
(C) | it shall not change such Grantor’s name, corporate structure (e.g., by merger, consolidation, change in corporate form or otherwise), chief executive office, type of organization or jurisdiction of organization unless it shall have (1) notified the Collateral Agent in writing, by executing and delivering to the Collateral Agent a completed Pledge Supplement, substantially in the form of Exhibit A attached hereto, |
- 13 -
together with all Supplements to Schedules thereto, at least five days prior to any such change or establishment, identifying such new name, identity, corporate structure, chief executive office, jurisdiction of organization and providing such other information in connection therewith as the Collateral Agent may reasonably request, (2) taken all actions reasonably necessary to maintain the continuous validity, perfection and the same priority of the Collateral Agent’s security interest in the Collateral intended to be granted and agreed to hereby, and (3) taken all other actions required pursuant to the Credit Agreement; | |||
(D) | it shall pay taxes and claims in accordance with Section 5.3 of the Credit Agreement; | ||
(E) | Intentionally Omitted; | ||
(F) | except as otherwise permitted in the Credit Agreement or any other Credit Agreement, it shall not take or permit any action which could impair the Collateral Agent’s rights in the Collateral; and | ||
(G) | it shall not sell, transfer or assign (by operation of law or otherwise) any Collateral except as otherwise in accordance with the Credit Agreement. |
- 14 -
- 15 -
- 16 -
- 17 -
- 18 -
(A) | each Grantor shall be entitled to exercise or refrain from exercising any and all voting and other consensual rights pertaining to the Investment Related Property or any part thereof for any purpose not inconsistent with the terms of this Agreement or the Credit Agreement; provided, no Grantor shall exercise or refrain from exercising any such right if the Collateral Agent shall have notified such Grantor that, in the Collateral Agent’s reasonable judgment, such action would impair the value of the Investment Related Property such that a Material Adverse Effect would result therefrom; it being understood, however, that neither the voting by such Grantor of any Equity Interest for, or such Grantor’s consent to, the election of directors (or similar governing body) at a regularly scheduled annual or other meeting of stockholders, partners or members, as applicable, or with respect to incidental matters at any such meeting, nor such Grantor’s consent to or approval of any action otherwise permitted under this Agreement and the Credit Agreement, shall be deemed inconsistent with the terms of this Agreement or the Credit Agreement within the meaning of this Section 4.4(c)(i)(A), and no notice of any such voting or consent need be given to the Collateral Agent; and | ||
(B) | the Collateral Agent shall promptly execute and deliver (or cause to be executed and delivered) to each Grantor all proxies, and other instruments as such Grantor may from time to time reasonably request for the purpose of enabling such Grantor to exercise the voting and other consensual |
- 19 -
rights, when and to the extent which it is entitled to exercise pursuant to clause (A) above; | |||
(C) | Each Grantor shall be entitled to receive and retain, and to utilize free and clear of the Lien hereof, any and all distributions, but only if and to the extent made in accordance with the provisions of the Credit Agreement and this Agreement; | ||
(D) | Upon the occurrence and during the continuation of an Event of Default: |
(1) | all rights of such Grantor to exercise or refrain from exercising the voting and other consensual rights which it would otherwise be entitled to exercise pursuant hereto shall cease and all such rights shall thereupon become vested in the Collateral Agent who shall thereupon have the sole right to exercise such voting and other consensual rights; and | ||
(2) | in order to permit the Collateral Agent to exercise the voting and other consensual rights which it may be entitled to exercise pursuant hereto and to receive all dividends and other distributions which it may be entitled to receive hereunder (x) each Grantor shall promptly execute and deliver (or cause to be executed and delivered) to the Collateral Agent all proxies, dividend payment orders and other instruments as the Collateral Agent may from time to time reasonably request and (y) each Grantor acknowledges that the Collateral Agent may utilize the power of attorney set forth in Section 6.1. | ||
(3) | All rights of each Grantor to receive distributions which it would otherwise be authorized to receive and retain pursuant to Section 4.4.1(c)(i)(C) hereof shall immediately cease and all such rights shall thereupon become vested in the Collateral Agent, which shall thereupon have the sole right to receive and hold as Pledged Collateral such distributions until such Event of Default is cured or waived. | ||
(4) | Notwithstanding anything to the contrary contained herein, (i) upon the cure or waiver of any such Event of Default, the Grantors shall automatically have the right to exercise the voting and consensual rights it would otherwise be entitled to exercise pursuant to the terms hereof and (ii) promptly after the cure or wavier of any such Event of Default, the Collateral Agent shall repay and deliver to each Grantor all cash and monies that such Grantor is entitled to retain pursuant to Section 4.4.1(c)(i)(C) which was not applied in repayment of the Secured Obligations. |
- 20 -
- 21 -
- 22 -
- 23 -
- 24 -
- 25 -
- 26 -
- 27 -
- 28 -
- 29 -
- 30 -
SECTION 5. | ACCESS; RIGHT OF INSPECTION AND FURTHER ASSURANCES; ADDITIONAL GRANTORS. |
- 31 -
- 32 -
- 33 -
- 34 -
- 35 -
- 36 -
- 37 -
(1) | all amounts and proceeds (including checks and other instruments) received by Grantor in respect of amounts due to such Grantor in respect of the Collateral or any portion thereof shall be received in trust for the benefit of the Collateral Agent hereunder, shall be segregated from other funds of such Grantor and shall be forthwith paid over or delivered to the Collateral Agent in the same form as so received (with any necessary endorsement) to be held as cash Collateral and applied as provided by Section 7.7 hereof; and | ||
(2) | Grantor shall not adjust, settle or compromise the amount or payment of any such amount or release wholly or partly any obligor with respect thereto or allow any credit or discount thereon. |
- 38 -
- 39 -
- 40 -
- 41 -
AURORA DIAGNOSTICS, LLC | ||||||
By: | /s/ Gregory A. Marsh | |||||
Name: Gregory A. Marsh | ||||||
Title: Vice President, Chief Financial Officer & Treasurer | ||||||
AURORA DIAGNOSTICS HOLDINGS, LLC | ||||||
By: | /s/ Gregory A. Marsh | |||||
Name: Gregory A. Marsh | ||||||
Title: Vice President, Chief Financial Officer & Treasurer | ||||||
AURORA GREENSBORO LLC AURORA LMC, LLC AURORA MASSACHUSETTS, LLC AURORA MICHIGAN, LLC AURORA NEW HAMPSHIRE, LLC BERNHARDT LABORATORIES, INC. C R COLLECTIONS, LLC COVENANT HEALTHCARE LAB, LLC CUNNINGHAM PATHOLOGY, L.L.C. GREENSBORO PATHOLOGY, LLC HARDMAN PATHOLOGY ADX, LLC LABORATORY OF DERMATOPATHOLOGY ADX, LLC MARK & KAMBOUR, LLC MARK & KAMBOUR HOLDINGS, INC. PATHOLOGY SOLUTIONS, LLC SEACOAST PATHOLOGY, INC. TWIN CITIES DERMATOPATHOLOGY, LLC | ||||||
By: | /s/ Gregory A. Marsh | |||||
Name: Gregory A. Marsh | ||||||
Title: Vice President, Chief Financial Officer & Treasurer | ||||||
[Signature Page] | Aurora — Pledge and Security Agreement |
BARCLAYS BANK PLC, as Collateral Agent, | ||||
By: | /s/ Diane Rolfe | |||
Name: Diane Rolfe | ||||
Title: Director | ||||
[SIGNATURE PAGE]
TO PLEDGE AND SECURITY AGREEMENT
[NAME OF GRANTOR] | ||||||
By: | ||||||
Name: | ||||||
Title: | ||||||
BARCLAYS BANK PLC, as Collateral Agent | ||||||
By: | ||||||
Name: | ||||||
Title: |
TO PLEDGE AND SECURITY AGREEMENT
(A) | Full Legal Name, Type of Organization, Jurisdiction of Organization, Chief Executive Office/Sole Place of Business (or Residence if Grantor is a Natural Person) and Organizational Identification Number of each Grantor: |
Chief Executive | ||||||||||||||||||
Office/Sole Place | ||||||||||||||||||
of Business (or | ||||||||||||||||||
Residence if | ||||||||||||||||||
Full Legal | Type of | Jurisdiction of | Grantor is a | |||||||||||||||
Name | Organization | Organization | Natural Person) | Organization I.D.# |
(B) | Other Names (including any Trade-Name or Fictitious Business Name) under which each Grantor has conducted business for the past five years: |
Full Legal Name | Trade Name or Fictitious Business Name/D.B.A. |
(C) | Changes in Name, Jurisdiction of Organization, Chief Executive Office or Sole Place of Business (or Principal Residence if Grantor is a Natural Person) and Corporate Structure within past five years: |
Name of Grantor | Date of Change | Description of Change |
(D) | Agreements pursuant to which any Grantor is found as debtor within past five years: |
Name of Grantor | Description of Agreement |
(E) | Financing Statements: |
Name of Grantor | Filing Jurisdiction(s) |
TO PLEDGE AND SECURITY AGREEMENT
Name of Grantor | Location of Equipment and Inventory |
TO PLEDGE AND SECURITY AGREEMENT
Name of Grantor | Date of Acquisition | Description of Acquisition |
Name of Issuer of Pledged LLC | ||
Name of Grantor | Interest/Pledged Partnership Interest | |
TO PLEDGE AND SECURITY AGREEMENT
Name of Grantor | Description of Letters of Credit | |
TO PLEDGE AND SECURITY AGREEMENT
TO PLEDGE AND SECURITY AGREEMENT
Name of Grantor | Commercial Tort Claims | |
TO PLEDGE AND SECURITY AGREEMENT
Pledgor: | [INSERT ADDRESS] Attention: Telecopier: | |||
Collateral Agent: | Barclays Bank PLC 745 Seventh Avenue New York, NY 10019 Attention: Diane Rolfe Telecopier: 212-526-5115 |
Issuer: | [INSERT ADDRESS] Attention: Telecopier: |
[NAME OF PLEDGOR] | ||||||
By: | ||||||
Name: | ||||||
Title: | ||||||
BARCLAYS BANK PLC, | ||||||
as Collateral Agent | ||||||
By: | ||||||
Name: | ||||||
Title: | ||||||
[NAME OF ISSUER] | ||||||
By: | ||||||
Name: | ||||||
Title: |
Very truly yours, | ||||||
BARCLAYS BANK PLC, as Collateral Agent | ||||||
By: | ||||||
Name: | ||||||
Title: |
TO PLEDGE AND SECURITY AGREEMENT
Debtor: | [INSERT ADDRESS] | |||
Attention: | ||||
Telecopier: | ||||
Collateral Agent: | Barclays Bank PLC | |||
745 Seventh Avenue | ||||
New York, NY 10019 | ||||
Attention: Diane Rolfe | ||||
Telecopier: 212-526-5115 | ||||
Securities Intermediary: | [INSERT ADDRESS] | |||
Attention: | ||||
Telecopier: |
[DEBTOR] | ||||||
By: | ||||||
Name: | ||||||
Title: | ||||||
BARCLAYS BANK PLC | ||||||
as Collateral Agent | ||||||
By: | ||||||
Name: | ||||||
Title: | ||||||
[NAME OF SECURITIES INTERMEDIARY], | ||||||
as Securities Intermediary | ||||||
By: | ||||||
Name: | ||||||
Title: |
TO SECURITIES ACCOUNT CONTROL AGREEMENT
Very truly yours, | ||||||
BARCLAYS BANK PLC, as Collateral Agent | ||||||
By: | ||||||
Name: | ||||||
Title: |
TO SECURITIES ACCOUNT CONTROL AGREEMENT
TO SECURITIES ACCOUNT CONTROL AGREEMENT
Very truly yours, | ||||||
BARCLAYS BANK PLC, as Collateral Agent | ||||||
By: | ||||||
Name: | ||||||
Title: |
TO PLEDGE AND SECURITY AGREEMENT
AURORA DIAGNOSTICS, LLC HARDMAN PATHOLOGY ADX, LLC LABORATORY OF DERMATOPATHOLOGY ADX, LLC TWIN CITIES DERMATOPATHOLOGY, LLC AURORA MASSACHUSETTS, LLC PATHOLOGY SOLUTIONS, LLC AURORA NEW HAMPSHIRE, LLC BERNHARDT LABORATORIES, INC. AURORA MICHIGAN, LLC C R COLLECTIONS, LLC CUNNINGHAM PATHOLOGY, L.L.C. SEACOAST PATHOLOGY, INC. AURORA GREENSBORO, LLC MARK & KAMBOUR, LLC MARK & KAMBOUR HOLDINGS, INC. GREENSBORO PATHOLOGY, LLC AURORA LMC, LLC COVENANT HEALTHCARE LAB, LLC | ||||
By: | ||||
Name: | ||||
Title: | ||||
AURORA DIAGNOSTICS HOLDINGS, LLC | ||||
By: | ||||
Name: | ||||
Title: | ||||
STATE OF | ||||
ss.: | ||||
COUNTY OF | ||||
[Notary Seal] |
App. Date/ Reg. | App. No./ | |||||||||||||||
Mark | Country | Date | Reg. No. | Owner | ||||||||||||
TO PLEDGE AND SECURITY AGREEMENT
AURORA DIAGNOSTICS, LLC HARDMAN PATHOLOGY ADX, LLC LABORATORY OF DERMATOPATHOLOGY ADX, LLC TWIN CITIES DERMATOPATHOLOGY, LLC AURORA MASSACHUSETTS, LLC PATHOLOGY SOLUTIONS, LLC AURORA NEW HAMPSHIRE, LLC BERNHARDT LABORATORIES, INC. AURORA MICHIGAN, LLC C R COLLECTIONS, LLC CUNNINGHAM PATHOLOGY, L.L.C. SEACOAST PATHOLOGY, INC. AURORA GREENSBORO, LLC MARK & KAMBOUR, LLC MARK & KAMBOUR HOLDINGS, INC. GREENSBORO PATHOLOGY, LLC AURORA LMC, LLC COVENANT HEALTHCARE LAB, LLC | ||||
By: | ||||
Name: | ||||
Title: | ||||
AURORA DIAGNOSTICS HOLDINGS, LLC | ||||
By: | ||||
Name: | ||||
Title: | ||||
STATE OF | ||||
ss.: | ||||
COUNTY OF | ||||
[Notary Seal] |
Company | Copyright Title | Registration Number | Registration Date | |||
TO PLEDGE AND SECURITY AGREEMENT
AURORA DIAGNOSTICS, LLC HARDMAN PATHOLOGY ADX, LLC LABORATORY OF DERMATOPATHOLOGY ADX, LLC TWIN CITIES DERMATOPATHOLOGY, LLC AURORA MASSACHUSETTS, LLC PATHOLOGY SOLUTIONS, LLC AURORA NEW HAMPSHIRE, LLC BERNHARDT LABORATORIES, INC. AURORA MICHIGAN, LLC C R COLLECTIONS, LLC CUNNINGHAM PATHOLOGY, L.L.C. SEACOAST PATHOLOGY, INC. AURORA GREENSBORO, LLC MARK & KAMBOUR, LLC MARK & KAMBOUR HOLDINGS, INC. GREENSBORO PATHOLOGY, LLC AURORA LMC, LLC COVENANT HEALTHCARE LAB, LLC | ||||
By: | ||||
Name: | ||||
Title: | ||||
AURORA DIAGNOSTICS HOLDINGS, LLC | ||||
By: | ||||
Name: | ||||
Title: | ||||
STATE OF | ||||
ss.: | ||||
COUNTY OF | ||||
[Notary Seal] |
TO PLEDGE AND SECURITY AGREEMENT
State of | Type of | Organizational | ||||||||
Company Name | Organization | Organization | I.D. | Chief Executive Office | ||||||
Aurora Diagnostics, LLC | DE | limited liability company | 4131081 | 11025 RCA Center Drive, Ste 300 Palm Beach Gardens, FL 33410, Palm Beach County | ||||||
Aurora Diagnostics Holdings, LLC | DE | limited liability company | 4162777 | 11025 RCA Center Drive, Ste 300 Palm Beach Gardens, FL 33410, Palm Beach County | ||||||
Hardman Pathology ADX, LLC | GA | limited liability company | 07022844 | 11025 RCA Center Drive, Ste 300 Palm Beach Gardens, FL 33410, Palm Beach County | ||||||
Aurora Michigan, LLC | MI | limited liability company | D1092P | 11025 RCA Center Drive, Ste 300 Palm Beach Gardens, FL 33410, Palm Beach County | ||||||
Aurora New Hampshire, LLC | NH | limited liability company | 568815 | 11025 RCA Center Drive, Ste 300 Palm Beach Gardens, FL 33410, Palm Beach County | ||||||
Laboratory of Dermatopathology ADX, LLC | NY | limited liability company | N/A | 11025 RCA Center Drive, Ste 300 Palm Beach Gardens, FL 33410, Palm Beach County | ||||||
Cunningham Pathology, L.L.C. | DE | limited liability company | 2977484 | 11025 RCA Center Drive, Ste 300 Palm Beach Gardens, FL 33410, Palm Beach County | ||||||
C R Collections, LLC | AL | limited liability company | 451104 | 11025 RCA Center Drive, Ste 300 Palm Beach Gardens, FL 33410, Palm Beach County | ||||||
Seacoast Pathology, Inc. | NH | corporation | 35974 | 11025 RCA Center Drive, Ste 300 Palm Beach Gardens, FL 33410, Palm Beach County | ||||||
Mark & Kambour, LLC | FL | limited liability company | L07000095772 | 11025 RCA Center Drive, Ste 300 Palm Beach Gardens, FL 33410, Palm Beach County |
State of | Type of | Organizational | ||||||||
Company Name | Organization | Organization | I.D. | Chief Executive Office | ||||||
Aurora Greensboro LLC | NC | limited liability company | 1002834 | 11025 RCA Center Drive, Ste 300 Palm Beach Gardens, FL 33410, Palm Beach County | ||||||
Greensboro Pathology, LLC | NC | limited liability company | 0062894 | 11025 RCA Center Drive, Ste 300 Palm Beach Gardens, FL 33410, Palm Beach County | ||||||
Aurora LMC, LLC | NV | limited liability company | E0797322007-1 | 11025 RCA Center Drive, Ste 300 Palm Beach Gardens, FL 33410, Palm Beach County | ||||||
Covenant Healthcare Lab, LLC | FL | limited liability company | L07000118215 | 11025 RCA Center Drive, Ste 300 Palm Beach Gardens, FL 33410, Palm Beach County | ||||||
Twin Cities Dermatopathology, LLC | MN | limited liability company | 2749837-2 | 11025 RCA Center Drive, Ste 300 Palm Beach Gardens, FL 33410, Palm Beach County | ||||||
Aurora Massachusetts, LLC | DE | limited liability company | 4742810 | 11025 RCA Center Drive, Ste 300 Palm Beach Gardens, FL 33410, Palm Beach County | ||||||
Pathology Solutions, LLC | NJ | limited liability company | 0400084729 | 11025 RCA Center Drive, Ste 300 Palm Beach Gardens, FL 33410, Palm Beach County a | ||||||
Bernhardt Laboratories, Inc. | FL | corporation | H070000263563 | 11025 RCA Center Drive, Ste 300 Palm Beach Gardens, FL 33410, Palm Beach County | ||||||
Mark & Kambour Holdings, Inc. | FL | corporation | P09000084310 | 11025 RCA Center Drive, Ste 300 Palm Beach Gardens, FL 33410, Palm Beach County |
Company | Present Names | Former Names | ||
Aurora Diagnostics, LLC | N/A | Summit Diagnostics LLC | ||
Hardman Pathology ADX, LLC | Hardman Pathology and Dermatology (used but not registered) | Aurora Georgia, LLC |
- 2 -
Company | Present Names | Former Names | ||
Aurora Michigan, LLC | Hilbrich Dermatopathology | N/A | ||
Pathology Laboratory | ||||
Kent Pathology Laboratory | ||||
Laboratory of Dermatopathology ADX, LLC | Laboratory of Dermatopathology | Aurora New York, LLC | ||
Seacoast Pathology, Inc. | Seacoast Cytology Support Systems (used but not registered) | N/A | ||
Mark & Kambour, LLC | Freepath, PL | Aurora Florida, LLC (entity was merged with and into Mark & Kambour, LLC) | ||
Greensboro Pathology, LLC | N/A | Greensboro Pathology Associates, P.A. | ||
Twin Cities Dermatopathology, LLC | N/A | Twin Cities Dermatopathology, P.A. | ||
Aurora Massachusetts, LLC | ADX Massachusetts, LLC | N/A | ||
DermDx — A Division of Seacoast Pathology (used but not registered) | ||||
Bernhardt Laboratories, Inc. | N/A | Bernhardt Laboratories, P.A. | ||
Harvey E. Bernhardt, M.D., P.A. |
Name of Grantor | Filing Jurisdiction | |
Aurora Diagnostics, LLC | Delaware Secretary of State | |
Aurora Diagnostics Holdings, LLC | Delaware Secretary of State | |
Hardman Pathology ADX, LLC | Georgia Superior Court County Clerk | |
Aurora Michigan, LLC | Michigan Department of State | |
Aurora New Hampshire, LLC | New Hampshire Department of State | |
- 3 -
Name of Grantor | Filing Jurisdiction | |
Laboratory of Dermatopathology ADX, LLC | New York Department of State | |
Cunningham Pathology, L.L.C. | Delaware Secretary of State | |
C R Collections, LLC | Alabama Secretary of State | |
Seacoast Pathology, Inc. | New Hampshire Department of State | |
Mark & Kambour, LLC | Florida Secured Transaction Registry | |
Aurora Greensboro LLC | North Carolina Secretary of State | |
Greensboro Pathology, LLC | North Carolina Secretary of State | |
Aurora LMC, LLC | Nevada Secretary of State | |
Covenant Healthcare Lab, LLC | Florida Secured Transaction Registry | |
Twin Cities Dermatopathology, LLC | Minnesota Secretary of State | |
Aurora Massachusetts, LLC | Delaware Secretary of State | |
Pathology Solutions, LLC | New Jersey Department of the Treasury | |
Bernhardt Laboratories, Inc. | Florida Secured Transaction Registry | |
Mark & Kambour Holdings, Inc. | Florida Secured Transaction Registry |
- 4 -
TO PLEDGE AND SECURITY AGREEMENT
Name of Grantor | Inventory, Equipment, Etc. | |
Aurora New Hampshire, LLC | Exeter Hospital 10 Buzell Avenue Exeter, NH 03833 Rockingham County | |
Anna Jaques Hospital 25 Highland Avenue Newburyport, MA 01950 Essex County | ||
Mark & Kambour, LLC | 4665 Ponce de Leon Blvd, Suite 1A Coral Gables, FL 33414 | |
1150 Campo Sano Avenue Coral Gables, FL 33146 | ||
4412 West Osborne Avenue Tampa, FL 33614 Hillsborough County | ||
Greensboro Pathology, LLC | 1200 N., Elm Street, Greensboro, NC 27401 | |
801 Green Valley Road Greensboro, NC 27408 | ||
501 N. Elm Avenue Greensboro, NC 27403 | ||
�� | 618 South Main Street Reidsville, NC 27320 | |
4380 Federal Drive, Ste 100 Greensboro, NC 27410 |
Name of Grantor | Inventory, Equipment, Etc. | |
Covenant Healthcare Lab, LLC | 3824 E US HWY 90 Lake City, FL 32060 | |
2126 North Young Blvd Chiefland, FL 32626 | ||
5106 Ohio Ave Live Oak, FL 32060 | ||
410 Dillard Ave Winter Garden, FL 34787 | ||
44 N.W. Hall of Fame Dr Lake City, FL 32055 | ||
Twin Cities Dermatopathology, LLC | 9909 South Shore Drive, Suite 2A Plymouth, MN 55441 | |
Pathology Solutions, LLC | 246 Industrial Way Eatontown, NJ 07724 | |
Bernhardt Laboratories, Inc. | 5008 Mustang Road Jacksonville, FL 32216 |
- 6 -
TO PLEDGE AND SECURITY AGREEMENT
% of | ||||||||||||||||||||
Stock | No. of | Outstanding | ||||||||||||||||||
Class of | Certificated | Certificate | Par | Pledged | Stock of the | |||||||||||||||
Grantor | Stock Issuer | Stock | (Y/N) | No. | Value | Stock | Stock Issuer | |||||||||||||
Aurora New Hampshire, LLC | Seacoast Pathology, Inc. | Common | Y | 4 | $ | .01 | 300 Shares | 100 | % | |||||||||||
Mark & Kambour, LLC | Mark & Kambour Holdings, Inc. | Common | Y | 1 | N/A | 100 Shares | 100 | % | ||||||||||||
Mark & Kambour Holdings, Inc. | Bernhardt Laboratories, Inc. | Common | Y | 4 | $ | .01 | 500 Shares | 100 | % |
% of | ||||||||||||
Outstanding | ||||||||||||
LLC | ||||||||||||
Interests of | ||||||||||||
No. of | the Limited | |||||||||||
Limited Liability | Certificated | Certificate | Pledged | Liability | ||||||||
Grantor | Company | (Y/N) | No. | Units | Company | |||||||
Aurora Diagnostics Holdings, LLC | Aurora Diagnostics, LLC | Y | C-1 | 1000 Units / 100% | 100 | % | ||||||
Aurora Diagnostics, LLC | Hardman Pathology ADX, LLC | Y | C-2 | 1000 Units / 100% | 100 | % |
% of | ||||||||||||
Outstanding | ||||||||||||
LLC | ||||||||||||
Interests of | ||||||||||||
No. of | the Limited | |||||||||||
Limited Liability | Certificated | Certificate | Pledged | Liability | ||||||||
Grantor | Company | (Y/N) | No. | Units | Company | |||||||
Aurora Diagnostics, LLC | Aurora Michigan, LLC | Y | C-1 | 1000 Units / 100% | 100 | % | ||||||
Aurora Diagnostics, LLC | Aurora New Hampshire, LLC | Y | C-1 | 1000 Units / 100% | 100 | % | ||||||
Aurora Diagnostics, LLC | Laboratory of Dermatopathology ADX, LLC | Y | C-2 | 1000 Units / 100% | 100 | % |
- 8 -
Bank or | ||||||||||
Company | Broker | Address | Account No. | Account Type | ||||||
Aurora Diagnostics, LLC | Bank of America | 625 N Flagler Dr, 10th Fl West Palm Beach, FL 33401 | 4426372965 | Disbursements | ||||||
Aurora Diagnostics, LLC | Bank of America | 625 N Flagler Dr, 10th Fl West Palm Beach, FL 33401 | 4426447191 | Payroll | ||||||
Aurora Michigan, LLC | Bank of America | 625 N Flagler Dr, 10th Fl West Palm Beach, FL 33401 | 4426431275 | Refunds | ||||||
Aurora Diagnostics, LLC | Bank of America | 625 N Flagler Dr, 10th Fl West Palm Beach, FL 33401 | 4426564142 | Refunds | ||||||
Cunningham Pathology, L.L.C. | Bank of America | 625 N Flagler Dr, 10th Fl West Palm Beach, FL 33401 | 4426442264/Lockbox 281100 | Commercial Deposits (ZBA to Corp) | ||||||
Aurora Diagnostics, LLC | Bank of America | 625 N Flagler Dr, 10th Fl West Palm Beach, FL 33401 | 4426372978 | Concentration | ||||||
Aurora Diagnostics, LLC | Bank of America | 625 N Flagler Dr, 10th Fl West Palm Beach, FL 33401 | 4426447227 | Pass-Thru (ZBA to Distribution) | ||||||
Aurora Florida, LLC1 | Bank of America | 625 N Flagler Dr, 10th Fl West Palm Beach, FL 33401 | 4426373016 | Commercial Deposits (ZBA to Corp) | ||||||
Laboratory of Dermatopathology ADX, LLC | Bank of America | 625 N Flagler Dr, 10th Fl West Palm Beach, FL 33401 | 4426372981 / Lockbox 100521 | Commercial Deposits (ZBA to Corp) | ||||||
Aurora Michigan, LLC | Bank of America | 625 N Flagler Dr, 10th Fl West Palm Beach, FL 33401 | 4426373032 / Lockbox 100759 | Commercial Deposits (ZBA to Corp) |
1 | Account will eventually be switched to the name of Mark & Kambour, LLC. |
- 9 -
Bank or | ||||||||||
Company | Broker | Address | Account No. | Account Type | ||||||
Aurora New Hampshire, LLC | Bank of America | 625 N Flagler Dr, 10th Fl West Palm Beach, FL 33401 | 4426388289 / Lockbox 100519 | Commercial Deposits (ZBA to Corp) | ||||||
Aurora Michigan, LLC (Pathology Laboratory, P.C.) | Bank of America | 625 N Flagler Dr, 10th Fl West Palm Beach, FL 33401 | 4426388263 / Lockbox 100149 | Commercial Deposits (Path Lab) (ZBA to Corp) | ||||||
Hardman Pathology ADX, LLC | Bank of America | 625 N Flagler Dr, 10th Fl West Palm Beach, FL 33401 | 4426403436 / Lockbox 100681 | Commercial Deposits (ZBA to Corp) | ||||||
Aurora Michigan, LLC (Kent) | Bank of America | 625 N Flagler Dr, 10th Fl West Palm Beach, FL 33401 | 4426438472 / Lockbox 100763 | Commercial Deposits (ZBA to Corp) | ||||||
Greensboro Pathology, LLC | Bank of America | 625 N Flagler Dr, 10th Fl West Palm Beach, FL 33401 | 4426484727 | Refunds | ||||||
Greensboro Pathology, LLC | Bank of America | 625 N Flagler Dr, 10th Fl West Palm Beach, FL 33401 | 4426484714 / Lockboxes 100358 & 402027 | Commercial Deposits (ZBA to Corp) | ||||||
Mark & Kambour, LLC | Bank of America | 625 N Flagler Dr, 10th Fl West Palm Beach, FL 33401 | 4426484691 / Lockbox 100914 | Commercial Deposits (ZBA to Corp) | ||||||
Mark & Kambour, LLC | Bank of America | 625 N Flagler Dr, 10th Fl West Palm Beach, FL 33401 | 4426333399 | Refunds | ||||||
Covenant Healthcare Lab, LLC | Bank of America | 625 N Flagler Dr, 10th Fl West Palm Beach, FL 33401 | 4426338022 | Commercial Deposits (ZBA to Corp) | ||||||
Covenant Healthcare Lab, LLC | Bank of America | 625 N Flagler Dr, 10th Fl West Palm Beach, FL 33401 | 4426520746 | Petty Cash | ||||||
Twin Cities Dermatopathology, LLC | Bank of America | 625 N Flagler Dr, 10th Fl West Palm Beach, FL 33401 | 4426535676 / Lockbox 281177 | Commercial Deposits (ZBA to Corp) | ||||||
Aurora Diagnostics, LLC | Wachovia | 450 S. Australian Ave., W. Palm Beach, FL 33401 | 2000048944126 | Concentration |
- 10 -
Bank or | ||||||||||
Company | Broker | Address | Account No. | Account Type | ||||||
Aurora Diagnostics, LLC | Wachovia | 450 S. Australian Ave., W. Palm Beach, FL 33401 | 2000048944485 | Pass-Thru (ZBA to Concentration) | ||||||
Bernhardt Laboratories, Inc. | Wachovia | 450 S. Australian Ave., W. Palm Beach, FL 33401 | 2000050507315 | Commercial Deposits (ZBA to Corp) | ||||||
Pathology Solutions, LLC | Wachovia | 450 S. Australian Ave., W. Palm Beach, FL 33401 | 2000049216604 | Commercial Deposits (ZBA to Corp) | ||||||
Pathology Solutions, LLC | Wachovia | 450 S. Australian Ave., W. Palm Beach, FL 33401 | 2000017981592 | Deposits | ||||||
Greensboro Pathology, LLC | Wachovia | 450 S. Australian Ave., W. Palm Beach, FL 33401 | 2000048944139 / Lockboxes 602313 & 602320 | Commercial Deposits (ZBA to Corp) | ||||||
Twin Cities Dermatopathology, LLC | USBank | PO Box 1800, St. Paul, MN 55101 | 170211368205 | Refunds | ||||||
Bernhardt Laboratories, Inc.2 | Atlantic Coast Bank | 930 North University Boulevard Jacksonville, FL 32211 | 90510033 | Depository | ||||||
Bernhardt Laboratories, Inc.3 | Atlantic Coast Bank | 930 North University Boulevard Jacksonville, FL 32211 | 91159640 | Refunds | ||||||
Government Receivables Accounts | ||||||||||
Bank or | ||||||||||
Company | Broker | Address | Account No. | Account Type | ||||||
Laboratory of Dermatopathology ADX, LLC | Bank of America | 625 N Flagler Dr, 10th Fl West Palm Beach, FL 33401 | 4426372994 | Government Deposits (ZBA to Corp) |
2 | Pre-acquisition account to be replaced by Aurora Wachovia account in 2010 | |
3 | Pre-acquisition account to be replaced by Aurora Wachovia account in 2010 |
- 11 -
Bank or | ||||||||||
Company | Broker | Address | Account No. | Account Type | ||||||
Greensboro Pathology, LLC | Bank of America | 625 N Flagler Dr, 10th Fl West Palm Beach, FL 33401 | 4426484701 | Government Deposits (ZBA to Corp) | ||||||
Mark & Kambour, LLC | Bank of America | 625 N Flagler Dr, 10th Fl West Palm Beach, FL 33401 | 4426484688 | Government Deposits (ZBA to Corp) | ||||||
Cunningham Pathology, L.L.C. | Bank of America | 625 N Flagler Dr, 10th Fl West Palm Beach, FL 33401 | 4426438469 | Government Deposits (ZBA to Corp) | ||||||
Seacoast Pathology, Inc. | Bank of America | 625 N Flagler Dr, 10th Fl West Palm Beach, FL 33401 | 4426515560 | Government Deposits (ZBA to Corp) | ||||||
Hardman Pathology ADX, LLC | Bank of America | 625 N Flagler Dr, 10th Fl West Palm Beach, FL 33401 | 4426405214 | Government Deposits (ZBA to Corp) | ||||||
Covenant Healthcare Lab, LLC | Bank of America | 625 N Flagler Dr, 10th Fl West Palm Beach, FL 33401 | 4426338019 | Government Deposits (ZBA to Corp) | ||||||
Twin Cities Dermatopathology, LLC | Bank of America | 625 N Flagler Dr, 10th Fl West Palm Beach, FL 33401 | 4426535663 | Government Deposits (ZBA to Corp) | ||||||
Aurora Massachusetts, LLC | Bank of America | 625 N Flagler Dr, 10th Fl West Palm Beach, FL 33401 | 4426841496 | Government Deposits (ZBA to Corp) | ||||||
Bernhardt Laboratories, Inc. | Wachovia | 450 S. Australian Ave., W. Palm Beach, FL 33401 | 2000050874103 | Government Deposits (ZBA to Corp) | ||||||
Pathology Solutions, LLC | Wachovia | 450 S. Australian Ave., W. Palm Beach, FL 33401 | 2000049216659 | Government Deposits (ZBA to Corp) | ||||||
Greensboro Pathology, LLC | Wachovia | 450 S. Australian Ave., W. Palm Beach, FL 33401 | 2000048944142 | Government Deposits (ZBA to Corp) |
- 12 -
Name of Issuer of Pledged LLC | ||
Name of Grantor | Interest | |
Aurora Diagnostics, LLC | Cunningham Pathology, L.L.C. | |
Aurora Diagnostics, LLC | Aurora Greensboro LLC | |
Aurora Diagnostics, LLC | Mark & Kambour, LLC | |
Cunningham Pathology, L.L.C. | C R Collections, LLC | |
Aurora Greensboro LLC | Greensboro Pathology, LLC | |
Aurora Diagnostics, LLC | Aurora LMC, LLC | |
Aurora Diagnostics, LLC | Covenant Healthcare Lab, LLC | |
Aurora Diagnostics, LLC | Twin Cities Dermatopathology, LLC | |
Aurora Diagnostics, LLC | Skin Pathology ADX, LLC4 | |
Aurora Diagnostics, LLC | Aurora Massachusetts, LLC | |
Aurora Diagnostics, LLC | Pathology Solutions, LLC |
4 | Skin Pathology ADX, LLC was formed as an acquisition vehicle for Aurora Diagnostics, LLC in March 2008, but has not been capitalized. |
- 13 -
TO PLEDGE AND SECURITY AGREEMENT
- 15 -
TO PLEDGE AND SECURITY AGREEMENT
TO PLEDGE AND SECURITY AGREEMENT
Company | Copyright Title | Registration Number | Registration Date | Registration Type | ||||
PATHOLOGY SOLUTIONS, LLC | Tiger TCPC | TX0006919076 | December 3, 2007 | Computer File |
App. Date/ | ||||||||||||
Mark | Country | Status | Reg. Date | App. No./ Reg. No. | Owner | |||||||
AURORA DIAGNOSTICS | US | Registered | 6/10/2008 | 3446899 | Aurora Diagnostics, LLC | |||||||
AURORA DIAGNOSTICS | ||||||||||||
CAREDX | US | Pending | 3/14/2010 | 77/958,561 | Aurora Diagnostics, LLC | |||||||
CONNECTDX THE INFORMATION GATEWAY | US | Registered | 4/7/2009 | 3,601,123 | Aurora Diagnostics, LLC | |||||||
DERMDX | US | Registered | 5/11/2010 | 3,787,236 | Aurora Diagnostics, LLC | |||||||
GASTRODX | US | Pending | 2/16/2010 | 77/936,186 | Aurora Diagnostics, LLC | |||||||
ORALDX | US | Pending | 3/14/2010 | 77/958,560 | Aurora Diagnostics, LLC | |||||||
TREATMENTDX | US | Pending | 11/6/2009 | 77/866,993 | Aurora Diagnostics, LLC | |||||||
URODX | US | Registered | 5/11/2010 | 3,787,237 | Aurora Diagnostics, LLC | |||||||
WOMEN’SDX | US | Registered | 5/11/2010 | 3,787,239 | Aurora Diagnostics, LLC |
- 18 -
App. Date/ | ||||||||||||
Mark | Country | Status | Reg. Date | App. No./ Reg. No. | Owner | |||||||
CUNNINGHAM PATHOLOGY ASSOCIATES P.A. | US | Registered | 9/29/1981 | 1171727 | Cunningham Pathology, LLC | |||||||
Design Only | US State Alabama | Registered | 7/8/2003 | 105–093 | Cunningham Pathology, LLC | |||||||
- 19 -
TO PLEDGE AND SECURITY AGREEMENT
CREDIT AND GUARANTY AGREEMENT
AGREEMENT
EXHIBIT J-1
EXHIBIT J-2
EXHIBIT J-3
[LANDLORD] | ||||||
Name: | ||||||
Title: | ||||||
Address for Notices: | ||||||
Attention: | ||||||
Phone: | ||||||
Fax: | ||||||
BARCLAYS BANK PLC, | ||||||
as Collateral Agent | ||||||
By: | ||||||
Title: | ||||||
Address for Notices: | ||||||
Barclays Bank PLC, as Collateral Agent | ||||||
745 Seventh Avenue | ||||||
New York, NY 10019 | ||||||
Attention: Diane Rolfe | ||||||
Phone: 212-526-1109 | ||||||
Fax: 212-526-5115 |
EXHIBIT J-4
ACKNOWLEDGED AND AGREED: | ||||
[TENANT] | ||||
By: | ||||
Title: | ||||
Address for Notices: | ||||
Attention: | ||||
Phone: | ||||
Fax: | ||||
EXHIBIT J-5
CREDIT AND GUARANTY AGREEMENT
EXHIBIT K-1
1. | Applicable Margin. The Applicable Margin for each Series [___] New Term Loan shall mean, as of any date of determination, a percentage per annum as set forth belowplus the pricing premium, if any, less the pricing reduction, if any, in each case as set forth below: |
Series [__] New Term Loans | ||||||||
Total | LIBOR | |||||||
Leverage Ratio | Rate Loans | Base Rate Loans | ||||||
___:___ | % | % |
2. | Principal Payments. Borrower shall make principal payments on the Series [___] New Term Loans in installments on the dates and in the amounts set forth below,provided that (i) the weighted average life to maturity of the [Series [___]] New Term Loans shall be no shorter than the weighted average life to maturity of the Tranche B Term Loans and (ii) the applicable New Term Loan Maturity Date with respect to the [Series [___]] New Term Loans shall be no shorter than the later of final maturity of the Revolving Loans and the Tranche B Term Loans: |
[***************] | Insert completed items 1-7 as applicable, with respect to New Term Loans with such modifications as may be agreed to by the parties hereto to the extent consistent with Section 2.24 of the Credit Agreement. |
EXHIBIT K-2
(B) | ||
(A) | Scheduled | |
Payment | Repayment of | |
Date | Series [__] New Term Loans | |
$ | ||
$ | ||
$ | ||
$ | ||
$ | ||
$ | ||
$ | ||
$ | ||
$ | ||
$ | ||
$ | ||
$ | ||
$ | ||
$ | ||
TOTAL | $ |
EXHIBIT K-3
3. | Reductions in Connection with Voluntary and Mandatory Prepayments. Scheduled installments of principal of the [Series [___]] New Term Loans set forth above shall be reduced in connection with any voluntary or mandatory prepayments of the [Series [___]] New Term Loans in accordance with Sections 2.12, 2.13 and 2.14 of the Credit Agreement, respectively. | |
4. | Prepayment Fees. The Borrower agrees to pay to each New Term Loan Lender the following prepayment fees, if any: [ ]. | |
[Insert other additional prepayment provisions with respect to New Term Loans] | ||
5. | Other Fees. The Borrower agrees to pay each New Term Loan Lender its Pro Rata Share of an aggregate fee equal to [ ___, ___] on [ ___, ___]. | |
6. | Proposed Borrowing. This Agreement represents the Borrower’s request to borrow [Series [___] New Term Loans] from New Term Loan Lender as follows (the “Proposed Borrowing”): |
a. | Business Day of Proposed Borrowing: , ____ | |||||||
b. | Amount of Proposed Borrowing: $ | |||||||
c. | Interest rate option: | o | a. | Base Rate Loan(s) | ||||
o | b. | LIBOR Rate Loans | ||||||
with an initial Interest | ||||||||
Period of ____ month(s)] |
7. | [New Lenders. Each [New Term Loan Lender][New Revolving Lender] acknowledges and agrees that upon its execution of this Agreement [and the making of [New Term Loans] Series ___, New Term Loans][New Revolving Loans] that such [New Term Loan Lender][New Revolving Lender] shall become a “Lender” under, and for all purposes of, the Credit Agreement and the other Credit Documents, and shall be subject to and bound by the terms thereof, and shall perform all the obligations of and shall have all rights of a Lender thereunder.][***************] | |
8. | Credit Agreement Governs. Except as set forth in this Agreement, [Series [___] New Term Loans][New Revolving Loans] shall otherwise be subject to the provisions of the Credit Agreement and the other Credit Documents. |
[***************] | Insert bracketed language if the lending institution is not already a Lender. |
EXHIBIT K-4
9. | Borrower’s Certifications. By its execution of this Agreement, the undersigned officer, to the best of his or her knowledge, and the Borrower hereby certifies that: |
i. | The representations and warranties of the Credit Parties contained in the Credit Agreement and the other Credit Documents are true and correct in all material respects on and as of the date hereof to the same extent as though made on and as of the date hereof, except to the extent such representations and warranties specifically relate to an earlier date, in which case such representations and warranties were true and correct in all material respects on and as of such earlier date; | ||
ii. | No event has occurred and is continuing or would result from the consummation of the Proposed Borrowing contemplated hereby that would constitute a Default or an Event of Default; and | ||
iii. | Each Credit Party has performed in all material respects all agreements and satisfied all conditions which the Credit Agreement provides shall be performed or satisfied by it on or before the date hereof including, but not limited to, Section 2.24 thereof. |
10. | Borrower Covenants. By its execution of this Agreement, the Borrower hereby covenants that: |
i. | The Borrower shall deliver or cause to be delivered [a legal opinion reasonably acceptable to the Administrative Agent, together with]1 all [other] documents reasonably requested by Administrative Agent in connection with this Agreement; and | ||
ii. | Set forth on the attached Officers’ Certificate are the calculations (in reasonable detail) demonstrating compliance with the financial tests described in Section 6.8 (a) and (b) of the Credit Agreement. |
11. | [Eligible Assignee. By its execution of this Agreement, each [New Term Loan Lender][New Revolving Lender] represents and warrants that it is an Eligible Assignee.] |
12. | Notice. For purposes of the Credit Agreement, the initial notice address of each [New Term Loan Lender][New Revolving Lender] shall be as set forth below its signature below. |
13. | Non-US Lenders. For each [New Term Loan Lender][New Revolving Lender] that is a Non-US Lender, delivered herewith to Administrative Agent are such forms, certificates or other evidence with respect to United States federal income tax withholding matters as such [New Term Loan Lender][New Revolving Lender] may be required to deliver to Administrative Agent pursuant to the Credit Agreement. |
1 | Legal opinion to be delivered in connection with New Term Loans. |
EXHIBIT K-5
14. | Recordation of the New Loans. Upon execution and delivery hereof, Administrative Agent will record the [Series [___] New Term Loans][New Revolving Loans] made by [New Term Loan Lenders][New Revolving Lenders] in the Register. |
15. | Amendment, Modification and Waiver. This Agreement may not be amended, modified or waived except by an instrument or instruments in writing signed and delivered on behalf of each of the parties hereto. |
16. | Entire Agreement. This Agreement, the Credit Agreement and the other Credit Documents constitute the entire agreement among the parties with respect to the subject matter hereof and thereof and supersede all other prior agreements and understandings, both written and verbal, among the parties or any of them with respect to the subject matter hereof. |
17. | GOVERNING LAW. THIS AGREEMENT AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES HEREUNDER SHALL BE GOVERNED BY, AND SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK. |
18. | Severability. Any term or provision of this Agreement which is invalid or unenforceable in any jurisdiction shall, as to that jurisdiction, be ineffective to the extent of such invalidity or unenforceability without rendering invalid or unenforceable the remaining terms and provisions of this Agreement or affecting the validity or enforceability of any of the terms or provisions of this Agreement in any other jurisdiction. If any provision of this Agreement is so broad as to be unenforceable, the provision shall be interpreted to be only so broad as would be enforceable. |
19. | Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed to be an original, but all of which shall constitute one and the same agreement. Delivery of an executed counterpart of a signature page of this Agreement by telecopy, Adobe pdf file or other electronic transmission shall be effective as delivery of a manually executed counterpart of this Agreement. |
EXHIBIT K-6
[NAME OF LENDER] | ||||||
By: | ||||||
Name: | ||||||
Title: | ||||||
Notice Address: | ||||||
Attention: | ||||||
Telephone: | ||||||
Facsimile: | ||||||
[AURORA DIAGNOSTICS, LLC | ||||||
AURORA DIAGNOSTICS HOLDINGS, LLC | ||||||
HARDMAN PATHOLOGY ADX, LLC | ||||||
LABORATORY OF DERMATOPATHOLOGY ADX, LLC | ||||||
TWIN CITIES DERMATOPATHOLOGY, LLC | ||||||
AURORA MASSACHUSETTS, LLC | ||||||
PATHOLOGY SOLUTIONS, LLC | ||||||
AURORA NEW HAMPSHIRE, LLC | ||||||
BERNHARDT LABORATORIES, INC. | ||||||
AURORA MICHIGAN, LLC | ||||||
C R COLLECTIONS, LLC | ||||||
CUNNINGHAM PATHOLOGY, L.L.C. | ||||||
SEACOAST PATHOLOGY, INC. | ||||||
AURORA GREENSBORO LLC | ||||||
MARK & KAMBOUR, LLC | ||||||
MARK & KAMBOUR HOLDINGS, INC. | ||||||
GREENSBORO PATHOLOGY, LLC | ||||||
AURORA LMC, LLC | ||||||
COVENANT HEALTHCARE LAB, LLC] | ||||||
By: | ||||||
Title: |
EXHIBIT K-7
as Administrative Agent
By: | ||||
Title: |
EXHIBIT K-8
TO JOINDER AGREEMENT
Name of Lender | Type of Commitment | Amount | ||
[ ] | [New Term Loan Commitment] | $ | ||
Total: $ |
Name of Lender | Type of Commitment | Amount | ||
[ ] | [New Revolving Commitment] | $ | ||
Total: $ |
EXHIBIT K-A-9
CREDIT AND GUARANTY AGREEMENT
EXHIBIT L-1
EXHIBIT L-2
EXHIBIT L-3
USE OF PLEDGED COLLATERAL
EXHIBIT L-4
EXHIBIT L-5
EXHIBIT L-6
EXHIBIT L-7
EXHIBIT L-8
EXHIBIT L-9
EXHIBIT L-10
EXHIBIT L-11
EXHIBIT L-12
EXHIBIT L-13
EXHIBIT L-14
EXHIBIT L-15
EXHIBIT L-16
EXHIBIT L-17
EXHIBIT L-18
[NAME OF PLEDGOR], as Pledgor | ||||||
[NAME OF COMPANY] | ||||||
By: | ||||||
Title: |
EXHIBIT L-19
CREDIT AND GUARANTY AGREEMENT
EXHIBIT M-1
EXHIBIT M-2
EXHIBIT M-3
[NAME OF AURORA ENTITY] | ||||
By: | ||||
Name: | James C. New | |||
Title: | Chief Executive Officer | |||
[NOMINEE] | ||||
BARCLAYS BANK PLC as Collateral Agent | ||||
By: | ||||
Name: | ||||
Title: | ||||
EXHIBIT M-4
CREDIT AND GUARANTY AGREEMENT
EXHIBIT N-1
EXHIBIT N-2
EXHIBIT N-3
ASSIGNORS | ||||
AURORA DIAGNOSTICS, LLC | ||||
Name: James C. New | ||||
Title: Chief Executive Officer | ||||
[NAME OF THE SUBSIDIARY OF THE PARENT] | ||||
Name: | ||||
Title: | ||||
SELLER | ||||
COLLATERAL AGENT | ||||
BARCLAYS BANK PLC | ||||
Name: | ||||
Title: |
EXHIBIT N-4
CREDIT AND GUARANTY AGREEMENT
EXHIBIT O-1
EXHIBIT O-2
EXHIBIT O-3
[NAME OF AURORA ENTITY] | ||||
By: | ||||
Name: | ||||
Title: | ||||
[NAME OF DOCTOR PRACTICE] | ||||
By: | ||||
Name: | ||||
Title: | ||||
BARCLAYS BANK PLC as Collateral Agent | ||||
By: | ||||
Name: | ||||
Title: | ||||
EXHIBIT O-4
CREDIT AND GUARANTY AGREEMENT
P-1
P-2
P-3
[NAME OF AURORA ENTITY] | ||||
By: | ||||
Name: | ||||
Title: | ||||
[NAME OF PRACTICE] | ||||
By: | ||||
Name: | ||||
Title: | ||||
BARCLAYS BANK PLC as Collateral Agent | ||||
By: | ||||
Name: | ||||
Title: | ||||
P-4
CREDIT AND GUARANTY AGREEMENT
CREDIT AND GUARANTY AGREEMENT
1. | Assignor: | |||
2. | Assignee1: | |||
3. | Borrower: | Aurora Diagnostics, LLC | ||
4. | Administrative Agent: | Barclays Bank PLC, as the administrative agent under the Credit Agreement | ||
5. | Credit Agreement: | The $335,000,000 Credit and Guaranty Agreement dated as of ___ among Aurora Diagnostics, LLC, a Delaware |
1 | Must be an Affiliate Lender |
EXHIBIT R-1
limited liability company (“Borrower”), Aurora Diagnostics Holdings, LLC, a Delaware limited liability company (“Holdings”), certain subsidiaries of Borrower identified on the signature pages to the Credit Agreement as Guarantors, the Lenders parties thereto, Barclays Bank PLC, as Administrative Agent and Collateral Agent, and the other agents parties thereto. | ||||
6. | Assigned Interest: |
Aggregate Amount | Percentage | |||||||||||
of | Amount of | Assigned | ||||||||||
Commitments/Loans | Commitments/Loans | of Commitments/ | ||||||||||
Facility Assigned | for all Lenders | Assigned | Loans1 | |||||||||
Tranche B Term Loan | % | |||||||||||
[New Term Loan] | % |
1 | Set forth, to at least 9 decimals, as a percentage of the Commitment/Loans of all Lenders thereunder. |
EXHIBIT R-2
ASSIGNOR [NAME OF ASSIGNOR] | ||||||
By: | ||||||
Title: | ||||||
ASSIGNEE [NAME OF ASSIGNEE] | ||||||
By: | ||||||
Title: |
as Administrative Agent
By: | ||||
Title: | ||||
[Consented to:][*********] | ||||
AURORA DIAGNOSTICS, LLC | ||||
By: | ||||
Title |
[********] | To be added only if the consent of the Administrative Agent is required by the terms of the Credit Agreement. | |
[*********] | To be added only if the consent of the Borrower is required by the terms of the Credit Agreement. | |
[***] | To be added only if the consent of the Issuing Bank and Swing Line Lender is required by the terms of the Credit Agreement. |
EXHIBIT R-3
AGREEMENT
1. | Representations and Warranties. |
1.1 | Assignor. The Assignor (a) represents and warrants that (i) it is the legal and beneficial owner of the Assigned Interest, (ii) the Assigned Interest is free and clear of any lien, encumbrance or other adverse claim and (iii) it has full power and authority, and has taken all action necessary, to execute and deliver this Assignment and to consummate the transactions contemplated hereby; and (b) assumes no responsibility with respect to (i) any statements, warranties or representations made in or in connection with any Credit Document, (ii) the execution, legality, validity, enforceability, genuineness, sufficiency or value of the Credit Agreement or any other instrument or document delivered pursuant thereto, other than this Assignment (herein collectively the “Credit Documents”), or any collateral thereunder, (iii) the financial condition of the Borrower, any of its Subsidiaries or Affiliates or any other Person obligated in respect of any Credit Document or (iv) the performance or observance by the Borrower, any of its Subsidiaries or Affiliates or any other Person of any of their respective obligations under any Credit Document. | ||
1.2 | Assignee. The Assignee (a) represents and warrants that (i) it has full power and authority, and has taken all action necessary, to execute and deliver this Assignment and to consummate the transactions contemplated hereby and to become a Lender under the Credit Agreement, (ii) it satisfies the requirements, if any, specified in the Credit Agreement that are required to be satisfied by it in order to acquire the Assigned Interest and become a Lender, (iii) it is an Affiliate Lender, (iv) after giving effect to this Assignment, the aggregate principal amount of all Term Loans held by all Affiliate Lenders constitutes no more than 20% of the aggregate principal amount of all Term Loans then outstanding, (v) it has no material non-public information with respect to Holdings (or, following an IPO, with respect to Public Parent), or any of its direct or indirect Subsidiaries that has not been disclosed to the Lenders (other than Lenders that do not wish to receive material non-public information with respect to Holdings or any of its Subsidiaries), and if so disclosed could reasonably be expected to have a material effect upon, or otherwise be material to (A) the market price of the applicable Term Loan, or (B) the decision of an assigning Lender to sell, or of an assignee to purchase, such Term Loan, (vi) from and after the Effective Date, it shall be bound by the provisions of the Credit Agreement as a Lender thereunder and, to the extent of the Assigned Interest, shall have the obligations of a Lender thereunder, and (vii) it has received a copy of the Credit Agreement, together with copies of the most recent financial statements delivered pursuant to Section 5.1 |
EXHIBIT R-1
thereof, as applicable, and such other documents and information as it has deemed appropriate to make its own credit analysis and decision to enter into this Assignment and to purchase the Assigned Interest on the basis of which it has made such analysis and decision independently and without reliance on the Administrative Agent or any other Lender; and (b) agrees that (i) it will, independently and without reliance on the Administrative Agent, the Assignor or any other Lender and, based on such documents and information as it shall deem appropriate at the time, continue to make its own credit decisions in taking or not taking action under the Credit Documents, (ii) it will perform in accordance with their terms all of the obligations which by the terms of the Credit Documents are required to be performed by it as a Lender and (iii) in its capacity as a lender, it shall at all times be bound by the provisions of Section 10.27 of the Credit Agreement. |
2. | Payments. From and after the Effective Date, the Administrative Agent shall make all payments in respect of the Assigned Interest (including payments of principal, interest, fees and other amounts) to the Assignor for amounts which have accrued to but excluding the Effective Date and to the Assignee for amounts which have accrued from and after the Effective Date. |
3. | General Provisions. This Assignment shall be binding upon, and inure to the benefit of, the parties hereto and their respective successors and permitted assigns. This Assignment may be executed in any number of counterparts, which together shall constitute one instrument. Delivery of an executed counterpart of a signature page of this Assignment by telecopy, Adobe pdf file or other electronic transmission shall be effective as delivery of a manually executed counterpart of this Assignment. This Assignment shall be governed by, and construed in accordance with, the internal laws of the State of New York without regard to conflict of laws principles (other than Sections 5-1401 and 5-1402 of the New York General Obligations Law) thereof. |
EXHIBIT R-1
CREDIT AND GUARANTY AGREEMENT
CREDIT AND GUARANTY AGREEMENT
-2-
-3-
-4-
-5-
-6-
-7-
-8-
-9-
-10-
AURORA DIAGNOSTICS, LLC AURORA DIAGNOSTICS HOLDINGS, LLC HARDMAN PATHOLOGY ADX, LLC AURORA MICHIGAN, LLC AURORA NEW HAMPSHIRE, LLC LABORATORY OF DEMATOPATHOLOGY ADX, LLC CUNNINGHAM PATHOLOGY, L.L.C. C R COLLECTIONS, LLC SEACOAST PATHOLOGY, INC. MARK & KAMBOUR, LLC AURORA GREENSBORO, LLC GREENSBORO PATHOLOGY, LLC COVENANT HEALTHCARE LAB, LLC AURORA LMC, LLC TWIN CITIES DERMATOPATHOLOGY, LLC AURORA MASSACHUSETTS, LLC PATHOLOGY SOLUTIONS, LLC BERNHARDT LABORATORIES, INC. MARK & KAMBOUR HOLDINGS, INC. | ||||
By: | /s/ Gregory A. Marsh | |||
Name: Gregory A. Marsh | ||||
Title: Vice President, Chief Financial Officer & Treasurer | ||||
[Signature Page] | Aurora — Intercompany Subordination Agreement |
Administrative Agent and Collateral Agent
By: | /s/ Diane Rolfe | |||
Title: Director |
[Signature Page] | Aurora — Intercompany Subordination Agreement |